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ABSTRACT 
 
The lung contains numerous innate immune cells and effector proteins. One important 
component of this immune system is the surfactant protein-A (SP-A), which facilitates microbial 
clearance by opsonization and membrane permeabilization [1]. Pseudomonas aeruginosa (PA) is 
a major Gram-negative bacterial pathogen commonly associated with chronic lung infection in 
cystic fibrosis. In order to resist the antibacterial effects of SP-A, PA expresses various structural 
and secreted virulence factors. Previously, Wu et al (2003) have shown that Escherichia coli 
lipopolysaccharides (LPS) are important in resisting SP-A-mediated membrane permeabilization. 
Zhang et al (2005) performed a comparative signature-tagged mutagenesis screen to identify PA 
virulence factors needed to resist SP-A-mediated lung clearance, and identified PchA 
(isochorismate synthase) and PtsP (phosphoenolpyruvate protein phosphotransferase) as 
important for resisting SP-A-mediated membrane permeability. Zhang et al (2007) further 
showed that PA flagellum is important for resisting SP-A-mediated membrane permeabilization. 
Finally, Kuang et al (2011) have shown PA elastase degrades SP-A, allowing an avenue for PA 
to escape SP-A-mediated opsonization and membrane permeabilization.  
In this study, we demonstrated that type IV pilus (Tfp) is important in the resistance of 
lung clearance both in the presence and absence of SP-A. The Tfp-deficient mutant, ΔpilA, is 
severely attenuated in an acute pneumonia model of infection in the lungs of wild-type mice that 
it allows similar bacterial load as PAO1 in the lungs of SP-A
-/- 
mice. The ΔpilA bacteria are more 
susceptible to SP-A-mediated aggregation and opsonization. In addition, the integrity of the outer 
membranes of ΔpilA bacteria is compromised, rendering them more susceptible to SP-A-
mediated membrane permeabilization. By using Tfp extension and retraction mutants, we 
demonstrate that the increased susceptibility of ΔpilA to SP-A-mediated opsonization is caused 
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by the total absence of Tfp from PA cells. Finally, we provide evidence that increased expression 
of an 18 kDa nonpilus adhesin OprH in ΔpilA, may explain why there is an increased 
susceptibility to SP-A-mediated phagocytosis. 
In addition, we also have shown that Tfp glycosylation with O-antigen subunits allows 
for increased resistance to SP-A. We have also shown the glycosyltransferase mutant, 1244G7, 
which is deficient in O-antigen, is more susceptible to SP-A-mediated lung clearance and 
phagocytosis, but not membrane permeability. Finally, we have shown that the increase 
susceptibility of 1244G7 is associated with exposure of putative mannose residues.  
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CHAPTER 1: GENERAL INTRODUCTION 
 
I. Pseudomonas aeruginosa (PA) 
A. Cystic Fibrosis (CF) 
CF is the most common genetic disease in Caucasians, affecting approximately 30,000 
people in the United States or approximately 1 in 2,500 Caucasian newborns [2, 3]. Despite 
advances in medical therapy and infection prevention, the average life expectancy of CF patients 
is about 37-40 years of age [2, 4]. CF is caused by an autosomal recessive mutation of the ATP-
dependent and cAMP-regulated epithelial chloride channel, CF transmembrane conductance 
regulator (CFTR) [3, 5, 6]. This mutation causes epithelial dysfunction that leads to mucus 
obstruction, bronchopneumonia and chronic bacterial lung infection [7]. In addition to 
bronchopneumonia, CF could also cause pancreatic insufficiency, diabetes mellitus, biliary duct 
cirrhosis and dilation, and vas deferens and seminal vesicle aplasia or ectasia (Fig. 1a) [5, 8]. 
However, bronchopneumonia remains the major cause of morbidity and mortality in CF patients 
[8].   
1. CFTR 
Over 1800 CFTR mutations have been described [6, 9]. There are six classes of mutation: 1) 
premature termination signal, 2) defective processing, 3) defective phosphorylation, 4) defective 
conductance, 5) decrease production, and 6) defective regulation of other channels [3]. The first 
three types of mutation are associated also with pancreatic insufficiency [5]. Defective 
processing constitutes the most common class of CFTR mutation; of which, a three base pair 
deletion, F508del, is the most common [3, 5]. Absent or defective CFTR causes intracellular 
retention of chloride and hyperabsorption of sodium, as CFTR is an inhibitor of the epithelial 
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sodium channel eNaC [9]. There are several hypotheses about the mechanism by which the 
dysfunction in epithelial fluid regulation leads to chronic bacterial bronchopneumonia. Firstly, it 
is thought that the more acidic nature of trans-Golgi network in CF epithelial cells, caused by 
altered sodium conductance, leads to increased adherence of PA [10]. Secondly, epithelial cells 
with mutated CFTR have defective uptake of PA, allowing the bacteria to multiply in the 
alveolar lumen [11].  Thirdly, due to the defective chloride channel, airway surface fluid sodium 
and chloride concentrations are thought to increase to twice normal [12].The increase in NaCl 
concentration is thought to disrupt bactericidal activity of airway fluid antimicrobial factors, 
including the cationic peptide, β-defensin-1 [13, 14]. This hypothesis of hypertonic airway fluid 
concentration is disputed by others [15]. Instead, they observed that airway fluid in CF epithelial 
cells is isotonic; but there is a higher rate of both ions and water absorptions, leading to loss of 
periciliary fluid and hyperviscosity of the mucus [15]. This sticky mucus leads to impaired 
mucociliary clearance of microbial pathogen. Finally, studies have shown that CF lungs have 
impaired ability to regulate immune function. For example, the anti-inflammatory cytokine, IL-
10, is depleted in CF airway epithelial fluid, which may lead to enhanced inflammation [16]. CF 
lung epithelia have been shown to have an exaggerated proinflammatory response [17]. All the 
mentioned mechanisms increase the retention of bacteria in the airway epithelium, allowing 
chronic infection. This chronic infection eventually leads to a succession of ineffective chronic 
inflammation, destruction of pulmonary tissue by inflammatory cells and mediators and finally, 
loss of pulmonary function (Fig. 1 b & c) [6].  
2. Role of P. aeruginosa in the pathogenesis of CF  
Chronic lung infection is the major cause of morbidity and mortality of CF patients [8, 18]. 
Common bacterial pathogens associated with chronic pulmonary infection in CF are PA, 
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Staphylococcus aureus, Haemophilus influenzae, Burkholderia cephacia complex, 
Achromobacter xylosoxidans and Stenotrophomonas maltophila [5, 19]. Among these, PA is the 
most common pathogen, noted in 52.5% of patients in the United States Cystic Fibrosis 
Foundation Patient Registry [2].  
PA is an opportunistic, Gram-negative bacterial pathogen, commonly associated with acute 
or chronic infection of mechanically damaged (ventilator associated pneumonia), mechanically 
obstructed (cystic fibrosis, chronic obstructive pulmonary disease) or immunocompromised 
(HIV, malignancies, immunosuppressive drugs) lungs [20, 21]. In addition to lung infections, PA 
is also prevalent in contact lens associated keratitis, and a major cause of burn infections [22, 
23]. The ability of PA to cause disease is due to its large genome affording wide range of cell-
associated and excreted virulence factors and its genetic flexibility that affords it to adopt to 
different environmental conditions [20, 24]. Notable among these virulence factors are: 
lipopolysaccharide (LPS), flagellum, pyocyanin and type IV pilus.  
The first step of the chronic lung infection pathogenesis involves the adherence of PA to 
airway epithelial cells and respiratory mucins by expression of various virulence factors 
including, type IV pilus (Tfp), non-pilus adhesins and flagella [6, 25-28]. The epithelial receptors 
of Tfp are the glycosphingolipids, asialoGM1 and asialoGM2, specifically to the disaccharide 
GalNAcβ1-4Gal [27, 29, 30]. It is noted that the percentage of epithelial cells expressing 
asialoGM1 is increased in CF patients [27]. Other studies have shown that asialoGM1 also binds 
to LPS and flagella of PA [31, 32]. On the other hand, flagella cap protein FliD and flagellin are 
noted to bind with the glycoconjugate bearing Lewis X, present in respiratory mucins [28]. It is 
also noted that mucins of CF patients have high sialyl Lewis X expression [33, 34]. 
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Because of faulty mucociliary clearance, PA is able to establish long term colonization and 
infection in the CF airway epithelium [5, 15]. Another mechanism by which PA avoids 
phagocytosis by recruited neutrophils and resident macrophages is by penetrating deep within 
thick hypoxic mucus plugs and forming macrocolonies [35]. The combination of increased 
epithelial oxygen utilization as conferred by increase absorption of ions, very thick mucus, and 
oxygen consumption by both the bacterial macrocolonies and infiltrating neutrophils produce a 
hypoxic environment in these mucus plugs [35]. This hypoxic condition stimulates PA to 
produce the exopolysaccharide alginate, a major component of PA biofilms [35]. Biofilm further 
helps PA to avoid contact with phagocytes as well as decreases the penetration of antibiotics 
[35]. In addition to alginate, PA biofilms also contain rhamnolipids that can inactivate epithelial 
cilia, disrupt ion transport and enhance mucin release [36]. The expression of rhamnolipids, 
along with other virulence factors of PA, are regulated by quorum sensing molecules called 
homoserine lactones and quinolones [37]. PA biofilms also contain extracellular bacterial DNA 
that are important for activing neutrophils, contributing to the chronic inflammation 
characteristic of CF [38]. After establishing chronic colonization, PA initiates some phenotypic 
adaptations that prevent detection by the host lung immune system [39]. One such adaptation is 
the repression of flagellin production, by the presence of neutrophil elastase [40]. This repression 
is associated with resistance to phagocytosis as well as reduced proinflammatory response 
because flagellin is recognized by the host Toll like receptor-5 (TLR5) [41, 42]. CF isolates also 
lack Tfp; and pilus-deficient mutants have been shown to have lower proinflammatory cytokine 
production [17, 26]. In contrast, other phenotypic modifications increase inflammatory response, 
which is in line with CF pathogenesis towards lung tissue destruction. The LPS of PA isolates 
from CF patients contains more acylated lipid A, which has a more robust inflammatory 
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response than non-CF strains [43]. In addition, lipid A acylation is associated with increased 
resistance to host antimicrobial peptides [44, 45]. PA in CF lung also undergoes genetic 
mutations that facilitate selection of strains having traits beneficial for chronic infection. One 
such example is MexZ, the negative regulator of the multidrug efflux pump, MexXY-OprM, and 
the negative regulator of alginate biosynthetic genes, MucA [24, 46]. MucA also regulates the 
RNA polymerase sigma factor σ22, which negatively regulates Tfp and flagella [4]. PA also 
secretes some elastases that degrade antibodies, complement proteins, inflammatory cytokines 
and chemokines and surfactant protein A [47]. Another class of secreted virulence factors are the 
redox-active phenazines. Among the phenazines, pyocyanin increases the proinflammatory 
chemokine, IL-8 [48]. Finally, the PA toxin, CFTR inhibitory factor (cif), decreases the number 
of CFTR by inhibiting the deubiquitinating enzyme, USP10 [49].  
B. Type IV pilus (Tfp) 
Tfp are bacterial unipolar appendages, composed of homopolymer of thousands of pilin 
(PilA) subunits, found in many Gram-negative and one Gram-positive bacteria (Clostridium 
spp.) (Fig. 2) [50-53]. They are approximately 6-8 nm in diameter, and up to 4 µm in length [54]. 
In addition to PilA, there also a number of less abundant minor pilins: FimU, PilV/W/X/Y1/Y2 
and PilE) [53, 54]. Each pilin subunit is composed of a hydrophobic, N-terminal α-helix, β-
sheets, an αβ loop and a D-region marked by two cysteine residues that form disulfide bond [52]. 
The α-helix, which forms a hydrophobic core, contains an N-methylated terminal phenylalanine 
(α1) and a conserved glutamic acid (Glu5) [52]. The D-region of the final pilin subunit at the tip 
of a Tfp serves as ligand for receptor binding [52]. Unlike other pili, assembly of Tfp requires 
more than a dozen components, notable of which are: the subunit pilin (PilA), the outer 
membrane secretin (PilQ), the inner membrane platform protein that recruits ATPases (PilC), the 
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assembly polymerase (PilB), the disassembly polymerase (PilT/U) and the prepilin peptidase 
(PilD) (Fig. 3) [50, 53]. The expression of PilA is under the control of the alternative sigma 
factor, RpoN [55]. In addition, PilA expression is under the control of the two-component 
systems, PilR-PilS and AlgR-FimS, the complex chemosensory system ChpA, the global  carbon 
metabolism regulator Crc, and the virulence factor regulator Vfr [56-61].  
There are two major subfamilies of Tfp: Tfpa found in PA and Neisseria gonorrhoeae, and 
Tfpb found in enteric pathogens such as Vibrio cholerae and enteropathogenic Escherichia coli 
[53, 62, 63]. A subclass of Tfpb, Flp pili, is also encoded in PA [62]. These pili are not involved 
in motility, but are important for bacterial aggregation and biofilm formation [62]. Also, a PA 
strain, PA14, contains the pathogenicity island PAPI-1, which contains genes that encode for a 
Tfpb [63]. This Tfpb is involved in the conjugative transfer of PAPI-1 [63].  
PA can be grouped into 5 alleles based on the accessory gene flanking pilA; two of which are 
glycosyltransferases that decorate pilin with sugar (Group I and Group IV) [64]. Group I alleles 
(i.e. 1244 strain), which contain a glycosyltransferase that attaches one O-antigen repeating 
subunit per pilin subunit, are highly associated with CF and environmental isolates [64]. The O-
antigen repeating subunit was noted to be the trisaccharide, pseudaminic acid 
(5NβOHC47NFmPse)-(2→4)-Xylose-(1→3)-N-acetylfucosamine (FucNAc), bound to the serine 
residue 148 at the carboxyl terminal of the pilin subunit (Fig. 4) [65, 66]. The O-antigen glycan 
decorated in the Tfp is the product of the same O-antigen biosynthetic pathway for the LPS O-
antigen of the same strain [67].  
Among the many functions associated with Tfp are adhesion, twitching and swarming 
motility, DNA uptake, microcolony formation in biofilm, secretion of protease and colonization 
factors and eliciting immune response [50, 53]. Tfp is important for the initial attachment of PA 
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to airway epithelium. The residues 128-144 of the D-region of the tip pilin serves as the ligand 
for binding to airway epithelial receptor [52]. Several studies have indicated that the airway 
epithelial receptors of Tfp are the glycosphingolipids, asialoGM1 and asialoGM2 [27, 29, 30]. 
However, these remain controversial, as other studies show that clinical strains and some 
laboratory strains fail to bind to such receptors [68, 69]. Recent studies have shown that Tfp 
binds to the N-glycans in the apical surface of airway epithelial cells, facilitating internalization 
and activation of phosphatidylinositol-3-kinase (PI3K)/Akt activation [51, 70]. Adhesion to 
epithelial cells allows for injection of type III secretion system effector proteins [71]. 
Alternatively, internalization into airway epithelial cells can either be a pathway for PA to 
bypass the epithelial barrier and proceed to cause systemic infection, or be a defense mechanism 
of the host by shedding infected epithelia [51, 72]. Internalization of PA also has been shown to 
cause cytotoxicity to airway epithelium [70].  
Another important function of Tfp is twitching motility [53]. Unlike swimming motility 
which occurs in fluid medium, twitching motility occurs in moist, smooth, solid or semi-solid 
surfaces such as the airway mucosal epithelia [73]. PA moves in a highly organized fashion, 
aggregated in rafts, and aligned along their long axis [73]. This is facilitated by sequences of 
attachment to receptor or inert surface, retraction, and disengagement [52, 74]. This, in turn, is 
facilitated by the reversible disassembly (retraction) and assembly (extension) of pilin subunits 
[52]. Extension is facilitated by the ATPase motor PilB; while retraction is facilitated by the 
ATPase PilT/PilU [57, 75]. These motor ATPases, in turn, are regulated by the Chp 
chemosensory system, composed of the histidine kinase ChpA and the CheY-like response 
regulators, PilG (for extension) and PilH (for retraction) (Fig. 5) [57].  
Tfp also serves as the receptor for bacteriophage such as PO4 and F116 [76, 77].  
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Tfp has been shown to be important in surface attachment, forming microcolonies and 
remodeling during biofilm formation [75, 78]. More specifically, the twitching motility appears 
to be important for expansive migration and preventing further expansion of existing 
microcolonies [79]. PA biofilms are highly structured bacterial communities adhered to a 
surface, embedded within an alginate polysaccharide matrix as opposed to the free-swimming 
planktonic bacteria [78]. PA within biofilms have phenotypic and genotypic changes compared 
to planktonic bacteria due to adaptive mutations. PA within biofilms have been shown to 
upregulate algC, the alginate biosynthetic gene [80]. In addition, PA in biofilms are resistant to 
antibiotic treatment because of diffusion barrier created by the alginate matrix as well as 
selection of resistant bacteria [81]. In line with the mechanism of diffusion barrier, one of the 
genetic determinants that allows for antibiotic resistance is ndvB, which is required for 
production of periplasmic glucans [82]. Another mechanism by which PA become resistant to 
antibiotics is by lowering the metabolic activity as most antibiotics target metabolically active 
cells [83]. Another mechanism of resistance is the hyperproduction of beta-lactamase and 
overproduction of efflux pumps [83].  
II. Surfactant protein A (SP-A) 
The lung’s surfactant contains phospholipids and four major surfactant proteins: SP-A, B, C 
and D [84, 85]. SP-A and SP-D are collagen-containing C-type (calcium-dependent) lectins 
(collectins); of which, SP-A is the most abundant [84, 85]. Another member of the collectin 
family is the Mannose Binding Lectin (MBL) of the alternative complement pathway [86]. SP-A 
is produced by type II pneumocytes, bronchiolar Clara cells and the epithelium and glands of 
large airways (trachea, bronchi) [86-88]. Native SP-A is a bouquet-shaped, octadecamer (18 
subunits), composed of six trimers [84]. Each monomer contains an N-terminal, triple helical 
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collagen region that binds to eukaryotic receptor (SP-A receptor 210), and a C-terminal, globular 
carbohydrate recognition domain (CRD) that binds to microbial carbohydrates [84, 85, 89]. Two 
functional genes in chromosome 10 encode for human SP-A: SP-A1 and SP-A2 [86, 90]. It is 
thought that a trimer of native SP-A consists of two SP-A1 molecules and one SP-A2 molecule 
[91]. Of the more than 30 alleles characterized, ten occur at high frequency of more than 1% in 
the general population: SP-A1 alleles (6A, 6A
2
, 6A
3
, 6A
4
), SP-A2 alleles (1A, 1A
0
, 1A
1
, 1A
2
, 
1A
3
, 1A
5
) [90, 91]. There are only 10 amino acid differences between these more than 30 alleles 
[84]. SP-A1 contains an extra cysteine residue that is thought to allow greater oligomerization 
than SP-A2 [91]. Although SP-A1 has been shown to produce higher order oligomers, SP-A2 has 
been shown to induce more phagocytosis, greater aggregation and higher proinflammatory 
cytokine production [90-99].  
Through the CRD, SP-A binds and aggregates microbes, enhancing phagocytosis and 
facilitating lung clearance [1, 47, 84, 100-104]. In addition to opsonic phagocytosis, SP-A 
enhances phagocytosis directly [85, 105]. SP-A also increases production of reactive oxygen 
species (ROS) and nitric oxide by alveolar macrophages [106, 107]. SP-A
-/-
 mice are more 
susceptible to lung infection, with decreased bacterial clearance and macrophage phagocytosis 
[85, 108-110]. SP-A exerts antibacterial effects either as an opsonin that enhances phagocytosis 
by effector cells, or by directly permeabilizing microbial membranes (Fig. 6) [1, 47, 101, 102]. 
SP-A also stimulates chemotaxis of alveolar macrophages and neutrophils [111, 112].  
SP-A has also been shown to have anti-inflammatory/immune modulatory effects. Contrary 
to previous studies, SP-A has been shown to decrease ROS production by decreasing NADPH 
oxidase activity and has been shown to decrease nitric oxide production [110, 113, 114]. It was 
observed that both endogenous and exogenous SP-As inhibit LPS-induced production of TNF-α 
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[114]. Similarly, TNF-α and MIP-2 levels are higher in SP-A-/- mice [110]. In contrast, SP-A has 
also been shown to increase TNF-α mRNA and protein levels [115, 116]. It is speculated that 
SP-A and LPS share TLR4 as a receptor, explaining their similar and competitively inhibitory 
effects [115]. Inhibition by SP-A of LPS-induced immune response was shown to be via direct 
interaction of SP-A with LPS, preventing interaction of LPS and LPS binding protein (LBP) with 
TLR4 [117]. SP-A has also been shown to bind to components of the LPS receptor complex, 
including TLR4, CD14 and MD-2, regulating inflammatory response [118-120]. However, 
contrary to this, a recent study showed that SP-A does not co-localize with TLR4 [121]. Another 
study has shown that SP-A inhibition of cytokine production is independent of the CD14 
pathway [122]. In addition to TLR4, SP-A has also been shown to bind with TLR2, also 
downregulating TNF-α secretion [123]. More recently, SP-A regulation of immune response has 
been shown to be due to decreased phosphorylation of IκBα, a regulator of NF-κB, decreased 
nuclear translocation of p65, decreased phosphorylation of MAPK family, and decreased 
phosphorylation of Akt [124]. A recent article showed that SP-A modulates LPS induced 
inflammatory effects by promoting trafficking of TLR4 from early endosome to the post-Golgi 
compartment through β-arrestin 2 [121]. The contradictory roles of SP-A during inflammatory 
response is best illustrated mechanistically by Gardai et al [125]. These authors show that SP-A 
has a dual function (both as a pro-inflammatory and anti-inflammatory mediator) depending on 
its orientation and binding [125]. When there are no foreign organisms or cellular debris, the 
globular CRD of SP-A binds to the signal inhibitor regulator protein α (SIRPα) of resident cells 
and blocks inflammatory mediator production [125]. However, when there are foreign organisms 
or cellular debris, the globular CRD binds to them, while the collagen domain of SP-A binds to 
calreticulin/CD91 of cells to induce production of pro-inflammatory mediators [125].  
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Several studies have shown that SP-A levels are decreased in patients with CF [126-128]. 
One study showed that SP-A levels in the bronchoalveolar lavage of CF patients decreased to 
2.65 µg/ml from 12.35 µg/ml of control individuals [127]. It has been shown that one of the 
causes of this decrease is due to proteolytic degradation of SP-A into smaller molecular weight 
(< 20 kD) residues [128]. And, this degradation has been shown to be caused by PA elastase 
LasB and protease IV, providing an escape from SP-A-mediated phagocytosis and aggregation 
[47, 129-131]. In addition to proteolytic degradation by PA enzymes, SP-A is thought to be 
decreased in CF due to epithelial cell damage, caused by neutrophilic enzymes [132]. In addition 
to epithelial cell damage, peroxynitrite from infiltrating neutrophils causes nitration and decrease 
function of SP-A [133]. However, one study actually showed that SP-A concentration is higher 
in CF [134]. Thus, the concentrations of SP-A within CF airways may depend on the patient 
population that was sampled within individual studies. 
In addition to elastase and protease IV, PA uses several other virulence factors to resist the 
antibacterial effects of SP-A. SP-A has been shown to bind  and enhance phagocytosis only to 
rough but not smooth strains of bacteria, indicating that it binds to the lipid A moiety of LPS 
[118, 135, 136]. It is hypothesized that the steric constraint of the bulky O-antigen and core 
polysaccharide prevents binding of SP-A to lipid A [118]. By extension, this means that O-
antigen and core polysaccharide are important to resistance to SP-A-mediated opsonic 
phagocytosis. Rough strains of bacteria have also been shown to be more susceptible to SP-A-
mediated inhibition of TNF-α production and secretion as well as membrane permeability [1, 
118].  
More recently, a comparative signature-tagged mutagenesis screen was performed using a 
library of mutants to identify virulence factors of PA that allows for resistance to SP-A [100]. 
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They found that ΔpchA (isochorismate synthase) and ΔptsP (phosphoenolpyruvate protein 
phosphotransferase) to be more suscpetible to SP-A-mediated membrane permeability, but not 
opsonization [100]. ΔflgE (flagella hook protein), ΔfliC (flagellin) and mucoid, nonmotile CF PA 
isolates (lacking flagella) are also more susceptible to SP-A-mediated membrane permeability 
[101]. This increased susceptibility of flagella mutants is attributed to the inadequate amount of 
LPS, producing membrane instability [101]. Another study showed that ΔfliC is unable to 
produce adequate amounts of exoprotease needed to degrade SP-A [102].  
III. Rationale of the project 
Morbidity and mortality of CF patients are most commonly associated with the chronic lung 
infections caused by PA [8, 18]. During chronic PA infection in CF cases, PA undergoes 
phenotypic changes that allow for increased survival and decreased detection by the innate and 
adapative immune systems [39]. More specifically, PA changes into a mucoid, nonmotile 
phenotype [35, 40]. The nonmotile phenotype is due to the absence of both flagella and Tfp [17, 
26, 40, 41, 53]. Previous investigators have shown that the flagellum is important for resistance 
of PA to SP-A-mediated antibacterial effects [101, 102]. Since SP-A levels are severely depleted 
in the CF airways, PA can safely turn off the flagella expression [126-128]. Thus, a novel 
intervention approach in treating CF patients might involve infusion of exogenous SP-A to help 
clear susceptible PA lacking flagellum. The first aim of this dissertation is to explore whether 
Tfp is important for resistance of PA to SP-A-mediated antibacterial effects, in the hopes of 
deciphering whether CF isolates that lack Tfp would be ideal candidate for treatment with 
exogenous recombinant SP-A. As discussed above, because the steric constraint of the bulky O-
antigen and core polysaccharide prevents binding of SP-A to lipid A [118], I hypothesized that 
O-antigen glycosylation of Tfp is a mechanism of resistance to SP-A. Thus, the second aim of 
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my dissertation was to decipher the functional interactions between Tfp glycosylation with O-
antigen and resistance to SP-A.   
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IV. FIGURES 
 
Fig. 1. (a) Organs affected by CF. (b) normal airway (c) cystic fibrosis airway. This drawing is 
taken from the NIH NHLBI website.  
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Fig. 2. A schematic drawing of a PA with unipolar appendages, Tfp and flagella. This drawing is 
adapted from [137]. IM=inner membrane; OM=outer membrane. 
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Fig. 3. A schematic drawing of Tfp assembly complex. This drawing is adapted from [53]. 
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Fig. 4. A schematic drawing of the O-antigen glycosylation of the PA strain 1244 Tfp. FucNac= 
N-acetylfucosamine; Pse acid=Pseudaminic acid.  
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Fig. 5. A schematic drawing of Chp chemosensory regulation system of Tfp. This drawing is 
adapted from [57]. Up-direction bold black arrow=extension; down-direction bold black 
arrow=retraction. 
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Fig. 6. A schematic drawing of an SP-A and its two main antibacterial functions. This drawing is 
adapted from [138].  
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CHAPTER 2: THE IMPORTANCE OF TYPE IV PILUS OF PSEUDOMONAS 
AERUGINOSA FOR RESISTANCE TO SURFACTANT PROTEIN-A-MEDIATED 
ANTIBACTERIAL EFFECTS
1
 
 
ABSTRACT 
 
Previously, our laboratory has shown that other PA virulence factors, namely LPS, 
flagella, elastase, PchA and Ptsp, are important for resistance to SP-A-mediated antibacterial 
effects. In this study, we investigated whether type IV pilus (Tfp) of PA was also important in 
the resistance of PA to antibacterial effects of SP-A. First, we used C3H wild-type and SP-
knockout (SP-KO) mice to investigate the importance of Tfp in resisting SP-A-mediated lung 
clearance. Then, to further explore the mechanism by which Tfp allows for this resistance, we 
used gentamicin exclusion assay and two commercially available membrane permeability kits to 
investigate Tfp’s importance for resistance to SP-A-mediated phagocytosis and membrane 
permeability, respectively. We also determined whether Tfp is important for SP-A-mediated 
aggregation as well as direct killing.  
To explain the mechanism by resistance is afforded, we tested previously known 
mechanism by other virulence factors. Having discovered that such mechanism does not apply to 
Tfp, we explored the possibility of increased nonpilus adhesins in Tfp mutants using gentamicin 
exclusion assay, ligand blot and mass spectrophotometry. Finally, we explored whether the 
absence of surface Tfp is the cause of increased susceptibility of Tfp mutant to SP-A-mediated 
phagocytosis. 
                                                          
1
 Reprinted, with permission, from Tan, R. et al. Type IV pilus of Pseudomonas aeruginosa confers resistance to 
antimicrobial activities of the pulmonary surfactant protein-A, Journal of Innate Immunity, Manuscript# 
JIN354304.indd DOI# 10.1159/000354304. © S. Karger AG, Basel. 
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INTRODUCTION 
 
PA is an opportunistic Gram-negative bacterial pathogen commonly associated with acute or 
chronic infection of mechanically damaged (ventilator associated pneumonia), 
immunocompromised (HIV, malignancies, immunosuppressive drugs) and mechanically 
obstructed (cystic fibrosis, chronic obstructive pulmonary disease) lungs [20]. In addition to lung 
infections, PA is also prevalent in contact lens associated keratitis, and a major cause of burn 
infections [22, 23]. The reason for PA prevalence in many infections lies in its ability to 
elaborate a wide array of virulence factors, to form biofilms [25], as well as its intrinsic high 
levels of resistance to many antibiotics [139].  
 Among the virulence factors expressed by PA is the unipolarly-localized surface appendage, 
Tfp [25]. Tfp-deficiency attenuates the ability of PA to induce epithelial cytotoxicity, 
pneumonia, septicemia and mortality in mice [77, 140]. Tfp is important for twitching motility, 
epithelial adhesion, substratum attachment and biofilm formation, and phage attachment and 
uptake [25, 52]. Tfp is made up of pilin monomers, encoded by the pilA gene [52, 141]. The 
assembly and disassembly of Tfp are powered by the ATPases PilB and PilT/U, respectively, 
producing twitching motility [52, 57]. These extension and retraction proteins are regulated by 
the Chp chemosensory system [57]. The asialoGM1 [25, 52, 141, 142] and N-glycan chains [51, 
70] located on the apical surface of the host epithelium are the main receptors for Tfp.  
 The lung’s surfactant contains phospholipids and four major surfactant proteins: SP-A, B, 
C and D [84, 85]. The naturally occurring octadecameric SP-A is the most abundant [84, 85]. 
Each monomer contains a N-terminal, triple helical collagen region that binds to eukaryotic 
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receptor (SP-A receptor 210), and a C-terminal carbohydrate recognition domain (CRD) that 
binds to microbial carbohydrates [84, 85, 89]. Binding of CRD domain to microbial 
carbohydrates aggregates microbes, enhancing their phagocytosis [1, 47, 84, 100-102]. In 
addition to opsonic phagocytosis, SP-A enhances phagocytosis directly [85, 105]. SP-A
-/-
 mice 
are more susceptible to lung infection, with decreased bacterial clearance and reduced 
macrophage phagocytosis [85, 108, 109]. Most recently, we and others have shown that SP-A 
directly permeabilizing microbial membranes [1, 47, 101, 102].  
 Previously, our laboratory has shown that several virulence factors of PA, including LPS, 
phosphoenolpyruvate transferase, isochorismate synthase, flagellum, and elastase B, confer 
resistance to SP-A-mediated antimicrobial effects [1, 47, 100-102]. In this project, we show that 
Tfp also plays a major role in PA resistance to SP-A-mediated phagocytosis and membrane 
permeabilization.  
MATERIALS AND METHODS 
 
 Bacterial Strains and Growth Conditions 
 The wild-type PA strain PAO1, ΔpilA and the genetically-complemented strain ΔpilA 
(comp), ΔchpA, ΔpilG, ΔpilB, ΔpilH, ΔpilT and ΔpilU were generously provided by Professor 
Joanne Engel (University of California-San Francisco) [57]. The ΔrpoN was purchased from the 
University of Washington Genome Sciences [143] (Table 1). PA strains were grown in Luria-
Bertani (LB) broth (Fisher Scientific, Fair Lawn, NJ) and stored at -80
0
C in 30% glycerol 
(Sigma-Aldrich Co., St. Louis, MO). Before each experiment, bacteria were streaked from frozen 
stock onto LB agar for 18 hr at 37
0
C. One colony from this streak was then cultured in 5 ml LB 
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broth to stationary phase (OD 600 nm ~ 3.0). OD is measured using a spectrophotometer, 
Genesys 10 UV (Thermo Scientific, Waltham, MA). 
  
 Mouse Clearance Assay 
 Wild-type C3H/HeN (SP-A
+/+
) mice were purchased from Harlan Laboratory (South 
Easton, MA). Isogenic SP-A
-/-
 mice were gifts from Dr. Francis McCormack (University of 
Cincinnati College of Medicine). Mouse experiments complied with the guidelines of the 
University of Illinois Institution of Animal Care and Use Committee (IACUC).  SP-A
+/+
 and SP-
A
-/-
 mice (n = 5) were given a single intranasal inoculation of 1 × 10
7
 PAO1 or ΔpilA strain ~ 18 
hr after infection, mice were euthanized using CO2; and mouse lungs were harvested for 
histology or bacterial enumeration as we have previously described [1, 100]. 
  
 In Vivo Phagocytosis Assay 
 The phagocytosis rates between different PA strains were compared using the gentamicin 
exclusion assay as previously described [47]. Briefly, C3H/HeN and C3H SP-A
-/-
 mice (n = 3) 
were given a single intranasal inoculation of 1 × 10
7
 PAO1 or ΔpilA strain. The mouse lungs 
were lavaged two hr later to collect the alveolar macrophages. The white blood cells were then 
incubated in PBS with 100 µg/ml gentamicin (Life Technologies, Grand Island, NY) to kill the 
remaining extracellular bacteria. The macrophages were lysed with 1% Triton X-100 solution 
(Fisher Scientific, Fair Lawn, NJ) for 5 minutes and serially diluted for PA enumeration (colony 
counting). The ratio of CFU counts between C3H/HeN and C3H SP-A
-/-
 mice was computed for 
the fold increase of phagocytosis mediated by SP-A.  
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 Purification of Human hSP-A  
 Discarded lung washings from anonymous alveolar proteinosis patients were generously 
provided by Professor Francis McCormack (University of Cincinnati College of Medicine). hSP-
A was purified as previously described in [144]. Briefly, raw lung washings, equilibrated with 1 
mM CaCl2 (Sigma-Aldrich Co., St. Louis, MO), was passed through Sepharose 6B
®
 (GE 
Healthcare, Uppsala, Sweden) column laden with mannose (Sigma-Aldrich Co., St. Louis, MO). 
The captured SP-A is then eluted using 2 mM EDTA 5 mM Tris-HCl (pH 7.4) elution buffer. 
The eluted fractions were dialyzed using 150 mM NaCl 5 mM Tris-HCl (pH 7.4) dialysis buffer 
to remove EDTA. The purity of hSP-A preparations was confirmed by Coomasie blue analysis. 
 
 Murine Macrophage Cell Line and In Vitro Phagocytosis Assay 
 Murine RAW 264.7 (ATCC# TIB-71) macrophages were maintained in DMEM 
supplemented with 10% FBS (Phenix Research Products, Candler, NC) at 5% CO2 and 37
0
C 
[47]. The phagocytosis rates between different PA strains were compared using the gentamicin 
exclusion assay. Briefly, 1 × 10
6
 RAW 264.7 macrophages/ml were plated in 6-well cell culture 
plates overnight at 37
0
C, 5% CO2. PA strains were pre-incubated with 12.5, 25 or 50 µg/ml hSP-
A in the presence of 2 mM CaCl2 for 1, 6 or 12 hr in a shaker at 37
0
C.  The resulting mixture was 
then incubated with the RAW 264.7 cells at a ratio of 10 bacteria:1 macrophage for 1.5 hr at 
37
0
C. The macrophages were then washed, and incubated with DMEM (Corning Inc, Manassas, 
VA) with 100 µg/ml gentamicin (Life Technologies, Grand Island, NY) to kill the remaining 
extracellular bacteria. The macrophages were lysed with 1% Triton X-100 solution (Fisher 
Scientific, Fair Lawn, NJ) for 5 minutes, and serially diluted for enumeration (colony counting). 
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The ratio of CFU between treated and untreated bacteria was computed for the fold increase of 
phagocytosis mediated by hSP-A.  
 
 Aggregation Assay  
 PA strains were transformed with the plasmid pUCP19 harboring a GFP gene by 
electroporation as previously described [47]. Bacterial aggregation were performed using 
stationary phase PA incubated with 25 µg/ml hSP-A and 2 mM CaCl2 for one hr in a shaker at 
37
0
C. Afterwards, 6 µl of mixture were placed in a glass slide. A cover slip was added, and 
sealed. Bacterial clusters were enumerated from 10 independent fields under a fluorescence 
microscope. 
  
 Membrane Permeabilization Assay 
  Membrane permeability effects of hSP-A were observed using both the thiol-specific 
fluorophore ThioGlo
®
 (Calbiochem, San Diego, CA) and phosphatase substrate Enzyme Labeled 
Fluorescence-97 (ELF-97
®
) (Molecular Probes, Carlsbad, CA), as previously described [1, 47, 
102]. ThioGlo
® 
measures thiol containing proteins that leaked out of bacteria; while ELF-97
®
 is 
a phosphatase substrate that goes inside the leaky bacteria. Stationary phase PA bacteria (n=3) 
were washed, and incubated with either 50 µg/ml hSP-A for 15 minutes at 37
0
C or 50 µg/ml total 
protein of bronchoalveolar lavage from either C3H WT or SP-A KO mice.  For the ThioGlo 
assay, the bacterial-SP-A mixture was sedimented, and the supernatant was incubated with 10 
µM ThioGlo reagent. Fluorescence was measured at excitation wavelength 405 nm and emission 
wavelength 535 nm. For the ELF-97 assay, the bacterial-SP-A mixture was directly incubated 
with 100 µM ELF-97 reagent. Fluorescence was measured at excitation 355 nm and emission 
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535 nm every 3 minutes for the duration of 90 - 120 min. Fluorescence measurement was read 
using a spectrophotometer SpectraMax Gemini EM
®
 (Molecular Devices, Sunnyvale, CA).  
 
 Bacterial Viability Assay 
 Stationary phase PA bacteria were washed, and incubated with either 50 µg/ml hSP-A for 
15 minutes at 37
0
C or 50 µg/ml total protein of bronchoalveolar lavage from either C3H WT or 
SP-A KO mice.  The bacterial were then stained with a combination of SYTO 9
®
 and propidium 
iodide from the commercial bacterial viability kit, LIVE/DEAD BacLight
®
 (Molecular Probes, 
Eugene, OR). The counts of dead and live bacteria were then counted in ten independent high 
power fields (400X) using a fluorescent microscope (Q Imaging, Surrey, BC). 
 
 Elastase Assay 
 Elastase production in the culture supernatant of stationary phase PA was evaluated using 
the Sensolyte
TM
 Red Protease Assay Kit (AnaSpec, Inc, San Jose, CA). Stationary phase PA 
bacteria (n=3) were centrifuge at 8000 rpm for 2 minutes. The supernatant was collected and 
measured for elastase level. Fluorescence was measured at excitation 546 nm and emission 575 
nm. Fluorescence measurement was read using a spectrophotometer SpectraMax Gemini EM
®
 
(Molecular Devices, Sunnyvale, CA). 
 
 Pyocyanin Assay  
 Pyocyanin in the bacterial-free culture supernatant of stationary phase PA (n=3) from LB 
broth or a low phosphate medium (20 mM succinic acid, 40 mM NH4Cl, 2 mM K2SO4, 0.014 g 
NAH2PO4, 1 M MOPS, 40 mM MgCl2, 100 mM CaSO4, 100 mM ZnCl2, 30 mM MnCl2, 30 
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mM Fe(NO3)3) were measured at OD 690 nm [102]. OD is measured using a spectrophotometer, 
Genesys 10 UV (Thermo Scientific, Waltham, MA). 
 
 SDS Lysis Assay 
 To assess membrane stability of PA strains, bacterial cell lysis was performed with 
0.25% SDS as previously described [101]. Stationary phase PA bacteria (OD 600 nm ~ 3.0) 
(n=3) were washed, and resuspended in PBS with 0.25% SDS (Sigma-Aldrich Co., St. Louis, 
MO). The OD 600 nm was measured every 10 min for 1 hr. OD is measured using a 
spectrophotometer, Genesys 10 UV (Thermo Scientific, Waltham, MA). 
 
 LPS Analysis 
 LPS was purified from stationary phase PA strains as follows: the bacteria were 
sedimented, and resuspended in 200 µl lysis buffer (2 g SDS, 4 ml 2-mercaptoethanol, 0.003 g 
bromophenol blue, 1 M Tris-Hcl pH6.8) and boiled for 10 min. 3 µl of 20 µg/µl Proteinase K 
(Qiagen Sciences, Germantown, MD) was added, and mixture was incubated for 1 hr at 60
0
C. 
The resulting mixture was separated in a SDS-PAGE gel. The resolved gel was incubated with a 
fixing solution (25% v/v isopropyl alcohol, 7% v/v acetic acid) overnight at 4
0
C, oxidized (0.7% 
periodic acid, 2.7% ethanol, 0.3% v/v acetic acid) for 5 min with gentle agitation, and washed 
with water for 30 minutes 3 times. The gel was then placed in staining solution (4% v/v 1 M 
NaOH, 5% v/v NH4OH, 2% AgNO3) and shaken for 10 minutes, followed by four 10-minute 
washes in water. Finally, the gel was developed (0.02% citric acid, 0.05% v/v formaldehyde) for 
20 minutes. The development was then stopped using a stop solution (0.8% v/v acetic acid). 
Photograph of the SDS-PAGE gel is taken.  
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 Transmission Electron Microscopy (TEM) 
PA strains were grown to OD 600 nm ~3.0 in LB broth at 37
0
C. Bacteria were washed with 
PBS, and subsequently fixed using Karnovsky fixative in phosphate buffered 2% Glutaraldeyde 
and 2.5 % Paraformaldehyde. TEM was performed at the University of Illinois Material 
Research Laboratory. Briefly, microwave fixation was used with this fixative and the tissue is 
then washed in cacodylate buffer with no further additives. The tissue was dehydrated in a series 
of increasing concentrations of ethanol. Acetonitrile was used as the transition fluid between 
Ethanol and the Epoxy. Infiltration series was done with an epoxy mixture using the epon 
substitute Lx112. The resulting blocks were polymerizred at 9
0
C overnight, trimmed and 
ultrathin sectioned with diamond knives. Sections were stained with Uranyl Acetate and Lead 
Citrate, and examined or photographed at 25,000X with an H600 Transmission Electron 
Microscope (Hitachi High Technologies America Inc, Schaumburg, IL). 
 
 Ligand Blot  
 Biotinylated SP-A was used to identify potential receptors in ΔpilA as previously 
described [89]. Briefly, SP-A was biotinylated using Biotin-N-hydroxysuccinimide ester (Pierce 
Chemical Co, Rockford, IL). Stationary phase bacteria were ruptured under 14,000 psi in a 
French Press (Spectronic Instruments, Rochester, NY). Membranes were isolated using 100 mM 
sodium carbonate and centrifuged at 115,000 g. Isolated membranes were solubilized using 50 
mM Tris pH 7.4, mixed with loading buffer, and boiled for 5 minutes, and loaded onto 15% 
SDS-PAGE gels. Gels were either stained using Coomassie blue or transferred to PVDF 
membranes (Biorad, Hercules, CA). Membranes were blocked for 2 hr, and subsequently 
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incubated with 3 µg/ml biotinylated SP-A. After three washings, streptavidin-conjugated HRP 
(EMD Millipore, Darmstadt, Germany) was added. Signal was detected using commercially 
available Western blot stain and substrate (Pierce Chemical Co, Rockford, IL). Ligand blot 
signal were analyzed with Image J software (rsbweb.nih.gov). Corresponding band in gels 
stained with Coomassie to the signal detected in PVDF membrane, were sent to the Chemistry 
Department for detection of suspected ligand receptor using LC-MS/MS.  
 
Statistical Analysis 
All comparisons of means are done using one-way student t-test. Significant difference was 
considered at p<0.05. 
 
RESULTS 
 
 The role of Type IV Pilus in SP-A-Mediated Lung Clearance  
 To determine the contribution of Tfp-mediated resistance to SP-A, we compared the 
virulence of the wild-type PA PAO1 and the isogenic ∆pilA mutant in a mouse model of acute 
pneumonia. Eighteen hours after intranasal inoculation with PAO1 or ΔpilA, SP-A+/+ mice 
showed signs of infection and respiratory distress but were not moribund. In contrast, PAO1-
infected SP-A
-/-
 mice were moribund and had to be euthanized (data not shown). The number of 
viable PAO1 or ∆pilA bacteria in SP-A-/- were 2.74 log (p=0.0001) and 1.97 log (p=0.0007) 
higher than in SP-A
+/+
 mice, respectively (Fig. 7a). The number of ∆pilA bacteria in SP-A-/- mice 
was statistically indistinguishable (p=0.15) when compared to the number of PAO1 the SP-
A
+/+
mice, suggesting that ∆pilA was more virulence during lung infection in the absence of SP-
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A. However, the viable counts of ∆pilA were 1.4 log lower (p=0.002) than PAO1 in SP-A+/+ 
mice, and was also 2.16 log lower (p=0.001) than PAO1 in SP-A
-/-
 mice.  Because the relative 
decrease of bacterial load between PAO1 and ΔpilA from SP-A-/- mice to SP-A+/+ mice is only 
0.77 log, this suggests that ∆pilA is in general less virulent. In addition, other lung innate 
immune factors within alveolar space may compensate for the absence of SP-A. Thus, a 
straightforward link between Tfp and SP-A cannot be easily established (Fig. 7a). The ΔpilA 
showed similar growth kinetics to that of PAO1, suggesting that the difference in mouse 
clearance was not due to the growth defects in the former (Fig. 7b). 
 The aforementioned quantitative observations were supported by histopathology (Fig. 8). 
In the absence of bacterial infection, histopathological features of SP-A
-/-
 mouse lungs were 
indistinguishable when compared to the lungs of SP-A
+/+
 mice (data not shown). PAO1 caused 
moderate bronchopneumonia (Fig. 8a) whereas the ∆pilA mutant only caused mild 
bronchopneumonia in the lungs of SP-A
+/+
 mice (Fig. 8b). In contrast, PAO1 caused severe 
bronchopneumonia in SP-A
-/-
 mice, with large amounts of pulmonary infiltrates and 
consolidation (Fig. 8c). Importantly, ∆pilA caused more severe pulmonary infiltrate in SP-A-/- 
mice (Fig. 8d) than the SP-A
+/+
 mice (Fig. 8b). The severity of ∆pilA-mediated 
bronchopneumonia in SP-A
-/-
 lungs (Fig. 8d) were similar to that caused by PAO1 in SP-A
+/+
 
lungs (Fig. 8a), suggesting that the virulence levels of ∆pilA in mouse lungs devoid of SP-A was 
similar to PAO1 in mouse lungs with sufficient SP-A. Collectively, these results indicate that Tfp 
plays an important protective role against anti-PA activity mediated by SP-A. 
 
 Type IV Pilus is Important for Resistance of SP-A-Mediated Phagocytosis 
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 To decipher the mechanism of Tfp resistance in SP-A-mediated lung clearance, we 
examined whether ΔpilA bacteria were more susceptible to SP-A-mediated opsonization. In the 
presence of 25 µg/ml SP-A, ΔpilA bacteria were phagocytized 5 times more efficiently 
(p=0.0001) than the wild-type PAO1 (Fig. 9a). The genetically-complemented ΔpilA(comp) 
bacteria were as resistant (p=0.04) to SP-A-mediated opsonization as PAO1 (Fig. 9a). These 
results were confirmed when using different concentrations of SP-A, which consistently showed 
that, in the presence of SP-A, ΔpilA was 2-3 times (p=0.0003 for 12.5 µg/ml; p=0.004 for 25 
µg/ml; p=0.02 for 50 µg/ml) more susceptible to phagocytosis by macrophages than PAO1 (Fig. 
9b).  
 We also examined the phagocytosis of ΔpilA in a time-dependent manner. Again, ΔpilA 
was more susceptible to SP-A-mediated opsonization at 1 (p=0.004) and 6 (p=0.002) hr after 
exposure to RAW 264.7 macrophages (Fig. 9c). However, prolonged exposure (12 hr) abolished 
phagocytosis, most probably because both PAO1 and ΔpilA bacteria degraded SP-A by secreting 
exoproteases, as we have previously described [47, 102]. These observations were confirmed by 
an in vivo phagocytosis assay, which showed that ΔpilA was 4.5 times (p=0.02) more susceptible 
to SP-A-mediated phagocytosis than PAO1 (Fig. 9d). The in vivo phagocytosis assay measures 
the total phagocytosis activity involving both alveolar macrophages and neutrophils (Fig 9d). 
Collectively, these results indicate that Tfp is important for resistance of SP-A-mediated 
opsonization. 
 
 Type IV Pilus is Important for Resistance of SP-A-Mediated Aggregation  
 One of the mechanisms by which SP-A enhances microbial phagocytosis is by increasing 
their aggregation, allowing more efficient phagocytosis [105]. We compared the aggregation of 
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wild-type PAO1 versus ΔpilA by SP-A in vitro. The ΔpilA mutant bacteria were aggregated by 
SP-A 4-fold (p=0.00002) higher than PAO1 per high power field (Fig. 10a-e). Overall, these 
results show that Tfp is important for resistance of SP-A-mediated aggregation.  
 
 Type IV Pilus is Important for Resistance of SP-A-Mediated Membrane Permeabilization  
 Apart from its ability to opsonize and facilitate the phagocytosis of microbes by 
macrophages, SP-A is also capable of directly killing bacteria by membrane permeabilization [1, 
100, 101]. We examined the susceptibility of ΔpilA to SP-A-mediated membrane 
permeabilization, by measuring the diffusion of an impermeable phosphatase substrate ELF97 
into PA cells, and by measuring the leakage of thiol-containing proteins. After 120 min of 
exposure, the ELF97 assay indicates that ΔpilA bacteria were permeabilized 2.1 fold higher than 
the PAO1 (Fig. 11a). In addition, the leakage of thiol-containing proteins increased by 1.81 fold 
(p=0.002) relative to PAO1 (Fig. 11b).  
To confirm our in vitro observations, we compared the ability of BALF of SP-A
+/+
 and SP-A
-
/-
 mice to permeabilize the membrane of PAO1 and ΔpilA (Fig 11c). The ΔpilA bacteria were 
more susceptible (p=0.00001) to BALF from SP-A
+/+
 mice than PAO1. In contrast, BALF from 
SP-A
-/-
 only possessed low levels (~ 900-1000 RFU) of membrane permeabilizing capability, 
suggesting that SP-A is an important membrane permeabilizing protein within the BALF.  
To determine whether increased susceptibility to membrane permeability leads to direct 
bacterial killing, we examined the bacterial viability after exposure to hSP-A and to BALF. 
Although both the hSP-A and the BALF from SP-A
+/+ 
mice only cause low levels of PA killing, 
the ΔpilA was consistently shown to be significantly more susceptible to direct killing by hSP-A 
(p=0.0002 for 1 hr; p=0.003 for 6 hr) (Fig 11d) and BALF of SP-A
+/+ 
mice (p=0.002) (Fig 11e). 
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These results suggest that SP-A-mediated membrane permeabilization contribute minimally to 
PA clearance.  
 
 Type IV Pilus-Mediated Resistance to SP-A-Mediated Phagocytosis is Independent of the 
Presence of the Appendages on the Cell Surface  
 Compared to other PA mutants we studied previously [47, 100-102], ∆pilA is uniquely 
more susceptible to both SP-A-mediated opsonization and membrane permeabilization. We 
examined both the pilin extension (ΔchpA, ΔpilG and ΔpilB) and the retraction (ΔpilH, ΔpilT and 
ΔpilU) mutants to determine if the presence of Tfp on the cell surface of PA is required for 
resistance to SP-A-mediated opsonization. As shown in Fig. 12a, mere absence of Tfp on the 
bacterial surface in the extension mutants (ΔchpA, ΔpilG, ΔpilB) does not increase (p=0.4 for 
ΔchpA; p=0.06 for ΔpilT; p=0.4 for ΔpilU) susceptibility to SP-A-mediated phagocytosis. 
Interestingly, the retraction mutants, ΔpilT and ΔpilU, which are hyperpiliated, are more resistant 
by 2.5 fold (p=0.0007 for ΔpilT; p=0.002 for ΔpilU) to SP-A-mediated opsonization (Fig. 12b).  
Both extension and retraction mutants were as resistant to SP-A-mediated membrane 
permeabilization as PAO1 (Fig. 12c-d). Collectively, these results suggest that the presence of 
pilin anchoring the membranes is adequate to confer resistance to SP-A-mediated phagocytosis. 
In addition, expression of additional Tfp (e.g., ΔpilT and ΔpilU mutants) offers in increased 
resistance to SP-A-mediated phagocytosis.  
 
 Increased Susceptibility of ΔpilA to SP-A-Mediated Phagocytosis is Probably Due to a 
Compensatory Increase in Nonpilus Adhesins  
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 Previous work in our laboratory has shown PA confers resistance to SP-A-mediated 
phagocytosis by increasing the degradation of SP-A through elastase B [47, 102], through 
mechanisms regulated by both flagellum and quorum-sensing. In addition, this process is 
regulated through flagellum and quorum sensing. Flagellar-deficient mutants are deficient in 
quorum sensing, decreasing their ability to produce adequate elastase B to degrade SP-A. 
However, ΔpilA produced wild-type levels of both quorum sensing regulated exoprotease 
activities (Fig. 13a) and the redox-active secondary metabolite pyocyanin (Fig. 13b). 
Furthermore, the ΔpilA lost its susceptibility to SP-A-mediated phagocytosis after 12 hr (Fig. 
13c), suggesting that SP-A was degraded. Thus, the lack of SP-A degradation is not the cause of 
enhanced opsonization of ΔpilA by SP-A.  
 Previous studies have shown that ΔpilA has higher binding affinity to host epithelial cells 
than the hyperpiliated ΔpilT and ΔpilU mutants [26, 55, 145, 146]. This is speculated to be 
caused by over-expression of alternative “nonpilus adhesins” in ΔpilA. The alternative sigma 
factor RpoN has been shown to regulate the expression of these adhesins [26, 55, 145, 146]. We 
hypothesized that one or more nonpilus adhesins may serve as ligands for binding to SP-A. We 
compared the phagocytosis of ΔpilA versus ΔrpoN::ISphoA/hah in the presence of SP-A. Fig. 
14a shows ΔrpoN::ISphoA/hah, which lacks the adhesins, is more resistant by 3-fold (p=0.02) 
and 8.5-fold (p=0.008) to SP-A-mediated phagocytosis than both with-type PAO1 and ΔpilA. 
Importantly, ligand blot and subsequent Image J analyses shows that the ΔpilA overexpresses by 
2-fold a protein of ~ 18 kDa compared to both PAO1 and rpoN::ISphoA/hah (Fig. 14b, c). 
LCMS/MS and micro-sequencing analyses indicated that this putative adhesin is the outer 
membrane protein H1 precursor OprH (PA1178) (Fig. 14d). Finally, rpoN::ISphoA/hah does not 
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exhibit increased susceptibility to SP-A-mediated membrane permeabilization, suggesting that 
these nonpilus adhesins are dispensable against the pore-forming function of SP-A (Fig. 14e).  
 
 ΔpilA Has Reduced Membrane Stability, Rendering it Susceptible to SP-A-Mediated 
Membrane Permeabilization  
 Next, we examined the potential mechanisms of increased susceptibility of ΔpilA to SP-
A-mediated membrane permeabilization. Previously, we have shown that the loss of LPS [1, 
100, 101] and flagellum [47, 101, 102] destabilizes membrane integrity, rendering them more 
susceptible to SP-A-mediated membrane permeabilization. In addition, Abeyrathne et al have 
shown that the O-antigen ligase mutant, ΔwaaL, which is unable to attach O-antigen to the core 
polysaccharide of LPS, has decreased or absent Tfp and flagella [147]. We examined whether the 
absence of Tfp destabilizes the membranes, through reduced expression of LPS. Qualitative 
analyses of both the LPS and the TEM images of bacterial membranes showed no discernible 
differences between ΔpilA and PAO1 (Fig. 15a-c). However, ΔpilA bacteria were more 
susceptible to lysis by 0.25% SDS, suggesting that the loss of pilin compromises the integrity of 
the outer membranes in the mutant bacteria (Fig. 15d).  
 
DISCUSSION 
 
 SP-A is a major pulmonary innate immunity protein that mediates microbial clearance 
through opsonization and membrane permeabilization. However, little is known about the 
mechanisms elaborated by microbial pathogens to confer resistance or susceptibility to SP-A. 
Previously, we have demonstrated that several PA factors —LPS, flagellum, isochorismate 
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synthase, phosphoenolpyruvate phosphotransferase that confer resistance to SP-A-mediated 
membrane permeabilization [1, 47, 100-102]. Flagellum also regulates quorum sensing-mediated 
expression of elastase B that degrades and disables SP-A-mediated opsonization during 
phagocytosis [1, 47, 100-102]. In this study, we found that Tfp of PA is uniquely important for 
resistance to SP-A-mediated opsonization and membrane permeabilization. Several lines of 
evidence support this conclusion: (i) ΔpilA is preferentially cleared in the lungs of SP-A+/+ mice 
compared to SP-A
-/-
 mice; (ii) ΔpilA is more susceptible to SP-A-mediated aggregation and 
opsonization; (iii) ΔpilA is more susceptible to SP-A-mediated membrane permeabilization; and 
(iv) the genetically complemented ΔpilA (comp) strain, which carries a copy of the wild-type 
pilA gene in trans, has restored resistance to SP-A-mediated opsonization and membrane 
permeabilization. 
 At face value, our current report seems to contradict previous findings, which show that 
Tfp-deficient PA strains, including ΔpilA, are more resistant to phagocytosis by macrophages 
[41, 148, 149]. However, this discrepancy can be explained because of different experimental 
contexts. Firstly, these previously published studies were pertaining to nonopsonin-mediated, 
fibronectin-dependent phagocytosis. Secondly, the number of phagocytized bacteria was 
quantified using a semi-quantitative fluorescent technique [41, 148, 149], rather than the 
quantitative method we used with the gentamicin exclusion assay.  
Detailed genetic analyses of the PA mutants defective in retraction and extension of Tfp 
reveal rather unexpected mechanisms by which the pilus mediates resistance to SP-A-mediated 
phagocytosis. For example, the extension gene mutants (ΔchpA, ΔpilG and ΔpilH) did not show 
increased susceptibility to SP-A-mediated phagocytosis. These results suggest that a total 
absence of pilA both intracellularly and extracellularly is required to render PA becoming 
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susceptible to SP-A-mediated opsonization. We postulate that the absence of pilA causes a 
compensatory increase of alternative ligands that actually interacts with SP-A. This is supported 
by previous studies showing that PA mutants with no Tfp (ΔpilA) have higher adhesion to 
epithelial cells than hyperpiliated Tfp extension mutants strains ΔpilT and ΔpilU, suggesting that 
Tfp-independent adhesins are responsible for increased binding to epithelial cells [26, 140]. 
Importantly, both hyperpiliated Tfp mutants strains ΔpilT and ΔpilU are significantly more 
resistant than the wild-type PAO1 to SP-A-mediated phagocytosis. These observations suggest 
that additional Tfp expressed by both ΔpilT and ΔpilU mutants may have masked the putative 
ligands, decreasing SP-A-mediated binding, aggregation and subsequent opsonization and 
enhanced phagocytosis by macrophages. 
With ligand blot, we have identified the putative nonpilus adhesion which is overexpressed in 
ΔpilA that may serve as ligands for SP-A binding. This nonpilus adhesion is probably regulated 
by the alternative sigma factor RpoN. Previous work has shown that RpoN positively regulates 
both pilin and flagellin production through their respective two-component systems PilRS and 
FleQR [146, 150]. Thus, ΔrpoN is deficient in the expression of Tfp and flagellum in PA. 
Interestingly, ΔpilA has been used as a model to study the expression of alternative nonpilus 
adhesins. In contrast, ΔrpoN has been used as a model for the lack of nonpilus adhesins [55, 145, 
146]. We speculate that the absence of Tfp causes RpoN to magnify the production of nonpilus 
adhesins, which serve as ligands for SP-A. This argument is supported by our analyses showing 
that ΔrpoN is even more resistant to SP-A-mediated phagocytosis than PAO1. Several studies 
have tried to identify of these nonpilus adhesins, with most of them focusing on those that bind 
to mucins [151-154]. Other studies focus on the role of nonpilus adhesins in nonopsonic 
phagocytosis [55, 145, 154]. However, the identity of these adhesins remains elusive. Another 
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complication is the uncertainty whether the alternative adhesins associated with binding to mucin 
are the same as those conferring susceptibility to SP-A-mediated phagocytosis. By using ligand 
blot, we have identified a putative non-pilus adhesin that binds SP-A. LC-MS/MS and micro-
sequenicng analyses show that the SP-A ligand is the 18 kDa outer membrane protein H1 
precursor (OprH). OprH expression is governed by low magnesium environment through the 
PhoP-PhoQ two component regulatory system [155, 156]. Interestingly, OprH has direct 
interactions with lipopolysaccharide [155]. Another outer membrane protein, P2 of Hemophilus 
influenzae, has been noted to be a receptor of SP-A [157]. We are currently constructing 
nonpolar deletion mutant and study the complex interaction of OprH with Tfp, RpoN, and SP-A. 
Furthermore, we are examining the sequence and functional homology between OprH and P2. 
Tfp interacts with glycoconjugates (e.g., asialoGM1) on the host epithelium [25]. 
Similarly, SP-A also interacts with glycoconjugates through its CRD domain. Thus, another 
possible mechanism of preferential clearance of ∆pilA mutant from mouse lungs is that SP-A 
may have blocked Tfp receptors, and preventing the binding of PA to the airway epithelium of 
wild-type mice. In contrast, in SP-A-/- mice, these Tfp receptors will be exposed, allowing better 
binding and colonization of PA to the lungs devoid of SP-A. Future studies will include 
performing comparative in vivo binding of wild-type versus various Tfp mutants to the lung 
epithelium of SP-A+/+ versus SP-A-/- mice.   
  Our experimental evidence demonstrates that Tfp also mediates resistance to SP-A-
mediated membrane permeabilization. Following exposure to SP-A, the integrity of the outer 
membranes is compromised, rendering the ΔpilA bacteria more permeable to the phosphotase 
substrate ELF97 into the cells and increased leakage of thiol containing intracellular proteins out 
of the cells. Previously, we have shown the the wild-type strain PAO1 is highly resistant to direct 
39 
 
killing by SP-A [102]. Although ΔpilA is more susceptible to SP-A-mediated membrane 
permeabilization, this only results in modest increase in direct killing of the bacteria, suggesting 
that the pore forming process may be transient. Qualitative LPS analysis and TEM examination 
of membrane structures did not reveal any gross alterations in ΔpilA. However, ΔpilA bacteria 
have reduced membrane stability as demonstrated by a modest increase of cell lysis by 0.25% 
SDS.  
 In conclusion, we have shown that Tfp of PA is important for resistance to SP-A-
mediated opsonization and membrane permeabilization. We provide evidence that Tfp functions 
to camouflage nonpilus adhesins, and prevents the binding of SP-A to these ligands and reduces 
opsonization and phagocytosis by macrophages. In addition, Tfp is necessary to stabilize 
bacterial membranes, rendering PA more resistant to SP-A-mediated membrane 
permeabilization. Adjunctive treatment regimen aimed at inhibiting Tfp may help improve the 
clearance of PA by augmenting the efficiency of SP-A in killing this important respiratory 
pathogen. 
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FIGURES AND TABLES 
TABLE 1. Bacterial strains and plasmids used in this study 
Strain or plasmid Description Reference 
P. aeruginosa strains 
     PAO1 Wild-type [57] 
     PAO1 ΔpilA In frame deletion of the pilA gene [57] 
     ΔpilA (comp)  Genetically-complemented ΔpilA 
mutant  
[57] 
     PAO1 – GFP PAO1 harboring pUCP19-gfp This study 
     ΔpilA – GFP ΔpilA harboring pUCP19-gfp  This study 
     ΔchpA In frame deletion of the chpA gene [57] 
     ΔpilG In frame deletion of the pilG gene [57] 
     ΔpilB In frame deletion of the pilB gene [57] 
     ΔpilH In frame deletion of the pilH gene [57] 
     ΔpilTCTX-pilU  In frame deletion of the pilT; pilU 
and 1 kb upstream sequence at 
attB site 
[57] 
     ΔpilU In frame deletion of the pilU gene [57] 
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     rpoN::ISphoA/hah Mutant harboring a ISphoA/hah 
transposon insertion into the rpoN 
gene 
University of Washington 
Genome Sciences  
Plasmids 
pUCP19-gfp pUCP19 plasmic expressing a 
green fluorescence protein 
[47] 
This table is adapted from Tan et al. Type IV pilus of Pseudomonas aeruginosa confers 
resistance to antimicrobial activities of the pulmonary surfactant protein-A. Journal of Innate 
Immunity. Manuscript# JIN354304.indd DOI# 10.1159/000354304. © S. Karger AG, Basel.  
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Fig. 7. ΔpilA bacteria are more susceptible to clearance by SP-A. (a) Respiratory tract infections 
with wild-type PAO1 versus ∆pilA were performed by intranasal inoculation of anesthetized SP-
A
+/+
 or SP-A
-/-
 mice. Mouse lungs were harvested 18 hours post infection for bacterial 
enumeration. Data are the mean CFU ± SE (n = 5 per group). 
*
p < 0.05 when comparing the 
bacterial loads between SP-A
+/+
 versus SP-A
-/-
 infected by PAO1 or ∆pilA. #p < 0.05 when 
comparing the bacterial loads between PAO1 versus ∆pilA infecting the SP-A+/+ or SP-A-/- mice. 
(b) The growth kinetics of PAO1 and ΔpilA bacteria were determined by measuring OD 600nm. 
The experiments were performed three times independently in triplicates. The representative 
growth curve from one out of three independent experiments is shown. This figure is adapted 
from Tan et al. Type IV pilus of Pseudomonas aeruginosa confers resistance to antimicrobial 
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activities of the pulmonary surfactant protein-A. Journal of Innate Immunity. Manuscript# 
JIN354304.indd DOI# 10.1159/000354304. © S. Karger AG, Basel.  
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Fig. 8. Histopathology of PA-infected lungs. SP-A
+/+
 and SP-A
-/-
 mice were infected with PAO1 
or ΔpilA as described in Fig. 1. Representative H&E-stained lung sections from SP-A+/+ and SP-
A
-/-
 mice (n = 5) 18-hour post intranasal instillation of PAO1 (a, c) and ∆pilA (b, d) bacteria. 
This figure is adapted from Tan et al. Type IV pilus of Pseudomonas aeruginosa confers 
resistance to antimicrobial activities of the pulmonary surfactant protein-A. Journal of Innate 
Immunity. Manuscript# JIN354304.indd DOI# 10.1159/000354304. © S. Karger AG, Basel.  
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Fig. 9. The ΔpilA mutant is more susceptible to SP-A-mediated opsonization. (a-c) RAW 264.7 
macrophages were infected with either PAO1 or ΔpilA in the presence or absence of hSP-A. The 
ratio of ingested bacteria was expressed as fold increase in phagocytosed bacteria due to the 
effect of hSP-A. (a) Phagocytosis of PAO1, ΔpilA and genetically complemented ΔpilA(comp) 
in the presence of 25 µg/ml hSP-A. (b) Phagocytosis of PAO1 and ΔpilA in the presence of 
different concentrations of hSP-A. (c) Time dependent phagocytosis of PAO1 versus ΔpilA in the 
presence of 25 µg/ml hSP-A. (d) In vivo phagocytosis of PAO1 versus ΔpilA in SP-A+/+ and SP-
A
-/-
 mice (n = 3). All phagocytosis experiments were independently performed three times in 
triplicates. The mean ± standard deviation from one representative experiment is shown. *p < 
0.05 when comparing the number of phagocytosed ∆pilA against PAO1. This figure is adapted 
from Tan et al. Type IV pilus of Pseudomonas aeruginosa confers resistance to antimicrobial 
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activities of the pulmonary surfactant protein-A. Journal of Innate Immunity. Manuscript# 
JIN354304.indd DOI# 10.1159/000354304. © S. Karger AG, Basel.  
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Fig. 10. ΔpilA bacteria are more susceptible to SP-A-mediated aggregation. GFP-expressing 
PAO1 and ΔpilA bacteria were incubated with 25 µg/ml hSP-A for 1 hour, and examined under a 
confocal fluorescence microscope. (a) PAO1 without hSP-A. (b) PAO1 with hSP-A. (c) ΔpilA 
without hSP-A. (d) ΔpilA with hSP-A. (e) The number of aggregates was averaged from 10 
independent high power field. *p < 0.05 when comparing the number aggregates in ∆pilA against 
PAO1. This figure is adapted from Tan et al. Type IV pilus of Pseudomonas aeruginosa confers 
resistance to antimicrobial activities of the pulmonary surfactant protein-A. Journal of Innate 
Immunity. Manuscript# JIN354304.indd DOI# 10.1159/000354304. © S. Karger AG, Basel.  
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Fig. 11. ΔpilA are more susceptible to SP-A-mediated membrane permeabilization. (a) ELF-97® 
assay. PAO1 and ΔpilA were preincubated with 50 µg/ml hSP-A for 15 minutes before the 
addition of ELF-97
®
. Absorbance was measured every 3 minutes at excitation wavelength 355 
nm and emission wavelength 535 nm, for a total of 90 minutes. (b) In vitro ThioGlo
®
 assay. 
PAO1, ΔpilA and ΔpilA comp were preincubated with 50 µg/ml hSP-A for 15 minutes. The 
bacterial-free supernatants were then mixed with ThioGlo
®
. Absorbance was measured at 
excitation wavelength 405 nm and emission wavelength 535 nm. *p < 0.05 when comparing the 
relative fluorescence unit (RFU) of ΔpilA against PAO1 and ΔpilA comp. (c) Ex vivo ThioGlo® 
assay. PAO1, ΔpilA and ΔpilA comp were preincubated with 50 µg/ml total protein of BALF 
from either SP-A
+/+ 
mice or SP-A
-/-
 mice for one hour. The bacterial free supernatants were then 
mixed with ThioGlo
®
. Absorbance was measured at excitation wavelength 405 nm and emission 
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wavelength 535 nm. #p < 0.05 when comparing the RFU of ΔpilA against PAO1 and ΔpilA in 
BALF from SP-A
+/+
 mice. *p < 0.05 when comparing the RFU of each PA strain in BALF from 
SP-A
+/+
 versus SP-A
-/-
 mice. (d) In vitro PA killing by hSP-A. PAO1 and ΔpilA were 
preincubated with 50 µg/ml hSP-A for one or six hour(s). The bacteria were then stained with a 
mixture of SYTO 9
®
 and propidium iodide for 15 minutes. The ratio of dead to live bacteria is 
counted in 10 high power fields. *p < 0.05 when comparing the ratio of dead to live ΔpilA versus 
PAO1 bacteria in the presence of hSP-A. (e) Ex vivo PA killing by mouse SP-A within BALF. 
PAO1 and ΔpilA were preincubated with 50 µg/ml total protein of BALF from either SP-A+/+ 
mice or SP-A
-/-
 mice for one hour. Bacterial viability was determined as in d. #p < 0.05 when 
comparing the ratio of dead to live bacteria between those treated with BALF from SP-A
+/+
 
versus SP-A
-/-
 mice. *p < 0.05 when comparing the ratio of dead to live PAO1 versus ΔpilA 
bacteria treated with BALF from SP-A
+/+
 mice. Experiments were performed independently 
three times in triplicates (for ELF
®
 and ThioGlo
®
 assays) or decuplicate (for Live Dead
®
 assay). 
Data from one typical experiment are shown. This figure is adapted from Tan et al. Type IV 
pilus of Pseudomonas aeruginosa confers resistance to antimicrobial activities of the pulmonary 
surfactant protein-A. Journal of Innate Immunity. Manuscript# JIN354304.indd DOI# 
10.1159/000354304. © S. Karger AG, Basel.  
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Fig. 12. The susceptibility of Tfp extension and retraction mutants to SP-A-mediated 
opsonization. (a-b) RAW 264.7 macrophages were infected with PAO1, ΔpilA, the extension or 
retraction mutants in the presence or absence of hSP-A. The ratio of ingested bacteria between 
those exposed to hSP-A versus those unexposed was expressed as fold increase in phagocytosis. 
(a) Phagocytosis of PAO1, ΔpilA and extension mutants ΔchpA, ΔpilG, ΔpilB. (b) Phagocytosis 
of PAO1, ΔpilA and retraction mutants ΔpilH, ΔpilT, ΔpilU. *p < 0.05 when comparing 
phagocytosis of PAO1 versus ΔpilA mutant. #p < 0.05 when comparing phagocytosis of PAO1 
versus ΔpilT and ΔpilU mutants. All experiments were independently performed three times in 
triplicates. The mean ± standard deviation from one representative experiment is shown. (c-d) 
Membrane permeabilization of PA strains by hSP-A. (c) Membrane permeabilization of PAO1, 
ΔpilA and extension mutants ΔchpA, ΔpilG, ΔpilB. (d) Membrane permeability of PAO1, ΔpilA 
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and retraction mutants ΔpilH, ΔpilT, ΔpilU. All experiments were independently performed three 
times in triplicates. The mean ± standard deviation from one representative experiment is shown. 
This figure is adapted from Tan et al. Type IV pilus of Pseudomonas aeruginosa confers 
resistance to antimicrobial activities of the pulmonary surfactant protein-A. Journal of Innate 
Immunity. Manuscript# JIN354304.indd DOI# 10.1159/000354304. © S. Karger AG, Basel.  
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Fig. 13. Resistance to SP-A-mediated phagocytosis is independent of quorum sensing. (a) 
Exoprotease activity of PAO1 versus ΔpilA. (b) Pyocyanin production of PAO1 versus ΔpilA. *p 
< 0.05 when comparing the exoprotease activity and pyocyanin OD 690nm in ∆pilA against 
PAO1. PO4=phosphate. This figure is adapted from Tan et al. Type IV pilus of Pseudomonas 
aeruginosa confers resistance to antimicrobial activities of the pulmonary surfactant protein-A. 
Journal of Innate Immunity. Manuscript# JIN354304.indd DOI# 10.1159/000354304. © S. 
Karger AG, Basel.  
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Fig. 14. Resistance to SP-A-mediated phagocytosis is regulated by RpoN. (a) Comparison of 
bacterial phagocytosis by RAW 264.7 macrophages between PAO1, ΔpilA and 
rpoN::ISphoA/hah in the presence or absence of 25 µg/ml hSP-A. All experiments were 
independently performed three times in triplicates. The mean ± standard deviation from one 
representative experiment is shown. 
*
p < 0.05 when comparing PAO1 versus ΔpilA. #p < 0.05 
when comparing PAO1 versus rpoN::ISphoA/hah. (b) Ligand blot analysis of nonpilus adhesins 
in PAO1, ΔpilA and rpoN::ISphoA/hah. (c) Image J analysis of the ligand blot. Protein 
expression was normalized to PAO1 as 100%. (d) Protein sequence of OprH. (e) Comparison of 
membrane permeabilization between PAO1, ΔpilA and rpoN::ISphoA/hah. The experiments 
were independently performed three times in triplicates. The mean ± standard deviation from one 
representative experiment is shown. 
*
p < 0.05 when comparing PAO1 versus ΔpilA and 
rpoN::ISphoA/hah. This figure is adapted from Tan et al. Type IV pilus of Pseudomonas 
aeruginosa confers resistance to antimicrobial activities of the pulmonary surfactant protein-A. 
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Fig. 15. ΔpilA is more susceptible to SDS-mediated cell lysis. (a) LPS analysis of PAO1 and 
ΔpilA as visualized using silver stain. (b & c) TEM of PAO1 and ΔpilA, respectively. Bar = 100 
nm. (d) SDS lysis assay. PAO1 and ΔpilA bacteria were incubated in 0.25% SDS solution. OD 
600nm was measured every 10 minutes. Bacterial lysis experiments were independently 
performed three times in triplicates. The mean from one representative experiment is shown. *p 
< 0.05 when comparing the OD 600 nm in ∆pilA against PAO1.This figure is adapted from Tan 
et al. Type IV pilus of Pseudomonas aeruginosa confers resistance to antimicrobial activities of 
the pulmonary surfactant protein-A. Journal of Innate Immunity. Manuscript# JIN354304.indd 
DOI# 10.1159/000354304. © S. Karger AG, Basel.  
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CHAPTER 3: O-ANTIGEN GLYCOSYLATION OF TYPE IV PILIN CONFERS 
RESISTANCE OF PSEUDOMONAS AERUGINOSA STRAIN 1244 TO SURFACTANT 
PROTEIN-A-MEDIATED OPSONIZATION 
 
ABSTRACT 
 
Previously, another investigator has shown that the addition of O-antigen subunit to Tfp pilin 
monomer allows for increased fitness to the strain 1244 over its cognate glycosyltransferase 
mutant. Here, we show that one of the possible mechanism of this increase fitness is the 
increased resistance of strain 1244 to SP-A-mediated phagocytosis. We have shown that while 
12447 does not cause mortality, 1244 causes mortality in the absence of SP-A. Using C3H WT 
and SP-A KO mice, we are able to show that while 1244G7 is statistically susceptible to SP-A-
mediated lung clearance; while 1244 is not. Using piperacillin exclusion assay, we have shown 
that 1244G7 is more susceptible to SP-A-mediated phagocytosis. Both 1244 and 1244G7 are 
equally susceptible to SP-A-mediated membrane permeability. Finally, we have shown that the 
increased susceptibility of 1244G7 to SP-A-mediated phagocytosis is associated with increased 
exposure of putative mannose receptors.  
 
INTRODUCTION 
 
Pseudomonas aeruginosa (PA) can be separated into five groups based on the presence or 
absence of varying downstream accessory gene flanking the Type IV pilin gene pilA [64]. The 
PilA of these five PA groups have varying amino acid sequence, length and presence of post-
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translational modification [64, 158]. The downstream accessory genes function either for pilin 
post-translational glycosylation/modification (Group I and Group IV) or in modulation of pilus 
assembly (Group III and Group V) [54, 64, 159]. 
Group I alleles (i.e. 1244 strain), which contain a glycosyltransferase (PilO/TfpO) that 
attaches one O-antigen repeating subunit per pilin subunit, is highly associated with CF and 
environmental isolates [64]. The O-antigen repeating subunit was noted to be the trisaccharide, 
pseudaminic acid (5NβOHC47NFmPse)-(2→4)-Xylose-(1→3)-N-acetylfucosamine (FucNAc), 
bound to the serine residue 148 at the carboxyl terminal of the pilin subunit [65, 66]. The O-
antigen glycan decorating PilA is the product of the same O-antigen biosynthetic pathway for the 
LPS O-antigen of the same strain [67]. Group II alleles do not contain an accessory flanking 
gene, and includes common laboratory strains, PAO1 and PAK [64]. Group III alleles contain 
the accessory gene, TfpY, and includes the human clinical isolate, PA14 [64]. PA14 was shown 
to produce lower LD50 and higher mortality rate than PAO1 [160]. This difference of virulence 
was partially attributed to ybtQ, a gene present in PA14 but not PAO1 [160]. Also, PA14, 
contains the pathogenicity island PAPI-1 and PAPI-2, which have been shown to contribute to 
virulence [161]. Group IV alleles contain two accessory genes, TfpW and TfpX [64]. The PilA 
of Group IV alleles are glycosylated with homo-oligomer of α-1,5-linked D-arabinofuranose, 
which are similar to the lipoarabinomannan polymer found in the cell wall of Mycobacteria spp. 
[158]. Group V alleles contain the accessory gene, TfpZ [64]. TfpY of Group III alleles and 
TfpZ of Group V alleles have been shown to be important for the surface expression of PilA 
[159].  
There are few studies exploring the virulence of the clinical strain 1244. It has been shown 
that strain 1244 is more virulent than its isogenic nonpilated mutants [77]. TfpO/PilO of Group I 
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alleles have been shown to allow for increased fitness of strain 1244 isolates when competed 
against its cognate glycosyltransferase mutant, 1244G7 [162].  
 
MATERIALS AND METHODS 
 
 Bacterial Strains and Growth Conditions 
 The wild-type PA strain 1244, the ∆tfpO mutant 1244G7, and the genetically-
complemented strain 1244G7 (comp) were generously provided by Professor Peter Castric 
(Duquesne University) [162]. Strain 1244 were grown in plain Luria-Bertani (LB) broth (Fisher 
Scientific, Fair Lawn, NJ); 1244G7 strains were grown in LB containing 75 µg/ml gentamicin 
(Life Technologies, Grand Island), NY; and 1244G7 (comp) strains were grown in LB 
containing 200 µg/ml carbenicillin (Lab Scientific Inc, Highlands, NJ)  at 37
0
C overnight. They 
were then stored at -80
0
C in 30% glycerol (Sigma-Aldrich, St Louis, MO). Before each 
experiment, bacteria were streaked from frozen stock onto LB agar with or without antibiotic for 
18 hr at 37
0
C. One colony from this streak was then cultured in 5 ml LB broth to stationary phase 
(OD 600 nm ~ 3.0). OD is measured using a spectrophotometer, Genesys 10 UV (Thermo 
Scientific, Waltham, MA). 
  
 Mouse Clearance Assay 
 Wild-type C3H/HeN (SP-A
+/+
) mice were purchased from Harlan Laboratory (South 
Easton, MA). Isogenic SP-A
-/-
 mice were gifts from Dr. Francis McCormack (University of 
Cincinnati College of Medicine). Mouse experiments complied with the guidelines of the 
University of Illinois Institution of Animal Care and Use Committee (IACUC).  SP-A
+/+
 and SP-
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A
-/-
 mice (n = 10) were given a single intranasal inoculation of 1 × 10
7
 PA strains 1244 or 
1244G7 strain ~ 18 hr after infection, mouse lungs were harvested for histology or bacterial 
enumeration as we have previously described [1, 100]. 
  
 In Vivo Phagocytosis Assay 
 The phagocytosis rates between different PA strains were compared using a modified 
gentamicin exclusion assay as previously described. Briefly, C3H/HeN and C3H SP-A
-/-
 mice (n 
= 3) were given a single intranasal inoculation of 1 × 10
7
 1244 or 1244G7. After two hr, the 
mouse lungs were lavaged to collect the alveolar macrophages and neutrophils. The white blood 
cells were then incubated in PBS with 100 µg/ml piperacillin (Sigma-Aldrich, St Louis, MO) to 
kill the remaining extracellular bacteria [163]. Piperacillin was used instead of gentamicin as 
1244G7 contain a gentamicin resistance cassette [162]. The macrophages were lysed with 1% 
Triton X-100 solution (Fisher Scientific, Fair Lawn, NJ) and serially diluted for PA enumeration. 
The ratio of CFU counts between C3H/HeN and C3H SP-A
-/-
 mice was computed for the fold 
increase of phagocytosis mediated by SP-A.  
 
 Purification of Human hSP-A  
 Discarded lung washings from anonymous alveolar proteinosis patients were generously 
provided by Professor Francis McCormack (University of Cincinnati College of Medicine). hSP-
A was purified as previously described in [144]. Briefly, raw lung washings, equilibrated with 1 
mM CaCl2 (Sigma-Aldrich, St Louis, MO), was passed through Sepharose 6B
®
 column (GE 
Healthcare, Uppsala, Sweden) ladened with mannose (Sigma-Aldrich, St Louis, MO). The 
captured SP-A is then eluted using 2 mM EDTA 5 mM Tris-HCl (pH 7.4) elution buffer. The 
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eluted fractions were dialyzed using the dialysis buffer (150 mM NaCl 5 mM Tris-HCl (pH 7.4)) 
to remove EDTA (Sigma-Aldrich, St Louis, MO). The purity of hSP-A preparations was 
confirmed by Coomasie blue analysis.  
 
 Murine Macrophage Cell Line and In Vitro Phagocytosis Assay 
 Murine RAW 264.7 (ATCC# TIB-71) macrophages were maintained in DMEM (Corning 
Inc, Mannassas, VA) supplemented with 10% FBS (Phenix Research Products, Candler, NC) at 
5% CO2 and 37
0
C [47]. The phagocytosis rates between different PA strains were compared 
using the modified gentamicin exclusion assay. Briefly, 1 × 10
6
 RAW 264.7 macrophages/ml 
were plated in 6-well cell culture plates overnight at 37
0
C, 5% CO2. RAW 264.7 cells were pre-
incubated with or without 1 mM D-mannose (Sigma-Aldrich, St Louis, MO) for 2 hours. PA 
strains were pre-incubated with 12.5, 25 or 50 µg/ml hSP-A in the presence of 2 mM CaCl2 for 
1, 6 or 12 hr in a shaker at 37
0
C.  The resulting mixture was then incubated with the RAW 264.7 
cells at a ratio of 10 bacteria:1 macrophage for 1.5 hr. The macrophages were then washed, and 
incubated with DMEM with 100 µg/ml piperacillin (Sigma-Aldrich, St Louis, MO) to kill the 
remaining extracellular bacteria. The macrophages were lysed with 1% Triton X-100 solution 
(Fisher Scientific, Fair Lawn, NJ), and serially diluted for enumeration. The ratio of CFU 
between treated and untreated bacteria was computed for the fold increase of phagocytosis 
mediated by hSP-A.   
  
 Membrane Permeabilization Assay 
  Membrane permeability effects of hSP-A were observed using both the thiol-specific 
fluorophore ThioGlo
®
 (Calbiochem, San Diego, CA), as previously described [1]. Stationary 
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phase PA bacteria were washed, and incubated with either 50 µg/ml hSP-A for 15 minutes at 
37
0
C or 50 µg/ml total protein of bronchoalveolar lavage from either C3H WT or SP-A KO 
mice.  For the ThioGlo assay, the bacterial-SP-A mixture was sedimented, and the supernatant 
was incubated with 10 µM ThioGlo reagent. Fluorescence was measured at excitation 
wavelength 405 nm and emission wavelength 535 nm. Fluorescence measurement was read 
using a spectrophotometer SpectraMax Gemini EM
®
 (Molecular Devices, Sunnyvale, CA). 
 
Statistical Analysis 
All comparisons of means are done using one-way student t-test. Significant difference was 
considered at p<0.05. 
 
RESULTS 
 
 The O-antigen Subunit on Tfp is Important for Resistance to SP-A-Mediated Lung 
Clearance  
 To determine the contribution of O-antigen on Tfp to resistance SP-A-mediated 
clearance, we compared the lung infection by the wild-type PA 1244 and the isogenic 
glycosyltransferase-deficient ∆tfpO mutant 1244G7 in a mouse model of acute pneumonia. 
Eighteen hr after intranasal inoculation with 1244, SP-A
+/+
 mice showed no mortality, while SP-
A
-/-
 showed 3/5 mortality. In contrast, SP-A
-/-
 mice infected with 1244G7 showed no mortality 
(Fig. 16c).  The number of viable 1244G7 bacteria in SP-A
-/-
 mice is significantly higher (2.39 
log) (0.0003) than in SP-A
+/+
 mice. In contrast, the burden of 1244 bacteria was only 1 log higher 
(p=0.06) in the SP-A
-/-
 mice than the SP-A
+/+
 mice (Fig. 16a). These data suggest that the 
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presence of O-antigen on pilins of Tfp allows for increased resistance to SP-A-mediated lung 
clearance.  
The aforementioned virulence observations were further supported by histopathological 
analysis of infected lungs (Fig. 17). 1244 caused severe bronchopneumonia (Fig. 17c) whereas 
the ∆tfpO mutant 1244G7 only caused mild to moderate bronchopneumonia in the lungs of SP-
A
-/-
 mice (Fig. 17d). In contrast, both 1244 and 1244G7 caused only mild to moderate 
bronchopneumonia in SP-A
+/+
 mice (Fig. 17 a-b).  
 
The Presence of O-antigen Subunit on Pilin of Type IV Pilus Allows for Increased 
Resistance to SP-A-Mediated Phagocytosis 
 To decipher the mechanism of increased resistance to SP-A-mediated lung clearance 
afforded by the presence of O-antigen on pilins, we examined whether 1244G7 bacteria were 
more susceptible to SP-A-mediated opsonization. In the presence of 12.5, 25 and 50 µg/ml SP-A, 
1244G7 bacteria were phagocytized 2-2.5 times more (p=0.02 for 12.5 µg/ml; p=0.0001 for 25 
µg/ml; p=0.02 for 50 µg/ml) efficiently than the wild-type 1244 (Fig. 18a). We also examined 
the phagocytosis of 1244G7 in a time-dependent manner. We found that 1244G7 was more 
susceptible to SP-A-mediated opsonization than 1244 only at 1 hr (p=0.0001) after exposure to 
RAW 264.7 macrophages (Fig. 18b). Prolonged exposure abolished the difference of phagocytic 
efficiency between 1244 and 1244G7, most probably due to production of exoproteases that 
degrade SP-A [47, 102]. These observations were confirmed by an 2 hr in vivo phagocytosis 
assay, which showed that 1244G7 was 4.5 times (p=0.003) more susceptible to SP-A-mediated 
phagocytosis than 1244 (Fig. 18c). The in vivo phagocytosis assay measures the total 
phagocytosis activity involving both alveolar macrophages and neutrophils.  
63 
 
 
The Increase Susceptibility of 1244G7 is due to Increased Susceptibility to Uptake by 
Mannose Receptor 
Previously, it was determined that SP-A increases the surface expression of mannose 
receptors in macrophages, resulting in increased phagocytosis [164, 165]. In order to determine 
whether the increase susceptibility of 1244G7 is due to increase susceptibility to uptake via 
mannose receptor, we pre-incubated RAW 264.7 cells with 1 mM D-mannose. We have shown 
that the increase susceptibility of 1244G7 to SP-A-mediated phagocytosis is abrogated (p=0.04) 
by the addition of mannose; while the addition of mannose did not affect the susceptibility of 
1244 (Fig. 19). 
 
The O-antigen on the Pilin of Type IV Pilus Does Not Confer Increased Resistance to SP-A-
Mediated Membrane Permeabilization  
 As mentioned previously, SP-A enhances microbial clearance by opsonization and 
membrane permeabilization. To further examine whether the presence of O-antigen on the pilin 
of Tfp allows also for increased resistance to SP-A-mediated membrane permeability, we used a 
commercially available membrane permeability kit measuring leaked thiol containing proteins. 
All three strains 1244, 1244G7 and 1244G7 (comp) were equally susceptible to SP-A-mediated 
permeability (Fig. 20), suggesting that susceptibility to membrane permeabilization is 
independent of pilin modification with the O- antigen.  
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DISCUSSION 
 
 The pilin subunits of the Group 1 PA strains, including 1244, are glycosylated with O-
antigen containing pseudaminic acid by the TfpO glycosyltransferase. TfpO of Group I PA has 
been shown to be important for the overall fitness of 1244 in the host.  In a mixed infection 
within mouse lungs, the ∆tfpO mutant 1244G7 is less competitive against the wild-type strain 
1244, [162]. However, these authors did not decipher the possible mechanism associated to this. 
One of their suggested mechanisms is that the glycosylated 1244 has enhanced resistance 
towards innate host defenses [162]. We propose that one of the mechanisms of higher fitness in 
the wild-type 1244 is due to the increase resistance to SP-A-mediated effects, afforded by the 
addition of O-antigen subunits to each pilin monomer on Tfp. Using mouse model of acute 
pneumonia infection, we have shown that 1244 caused mortality (3/5) when inoculated into SP-
A
-/-
 mice, but no mortality when inoculated in SP-A
+/+
 mice. This shows the importance of SP-A 
in innate immune resistance to the clinical strain 1244. Importantly, while 1244 caused mortality 
in the SP-A
-/-
 mice, the cognate glycosyltransferase ∆tfpO strain, 1244G7, did not. This 
implicates the O-antigen subunit as the cause of higher virulence in 1244 than 1244G7 in SP-A
-/-
 
mice. Using the bacterial burden within infected lungs as an indicator of lung clearance, we have 
shown that the log CFU is not statistically significantly different (p=0.06) between SP-A
+/+
 and 
SP-A
-/-
 mice after infection by 1244 infection. In contrast, the log CFU of 1244G7 strain is 
significantly higher in ths SP-A
-/-
 mice than in the SP-A
+/+
 mice (p=0.0003). These results 
suggest that the presence of O-antigen on the pilin subunits of Tfp confer resistance to 
antimicrobial properties of SP-A. This observations was reflected in the histopathology as 1244 
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in SP-A
-/-
 mice showed severe bronchopneumonia; while 1244 in SP-A
+/+
 and 1244G7 in both 
SP-A
+/+
 and SP-A
-/-
 only showed mild to moderate bronchopneumonia.  
To further decipher the mechanism of SP-A resistance by 1244, we explored whether the O-
antigen on the pilin subunits of Tfp confer resistance to SP-A-mediated opsonization or 
membrane permeability. The presence of O-antigen on pilin subunits of Tfp does not confer 
increased resistance to SP-A-mediated membrane permeability.    
We have shown that the wild-type clinical strain 1244 is consistently more resistant to SP-A-
mediated phagocytosis than its O-antigen-deficient mutant 1244G7 during in vitro phagocytosis 
assays. These results were confirmed by the in vivo phagocytosis assay, using bronchoalveolar 
lavage macrophage and neutrophils from SP-A
+/+
 and SP-A
-/-
 mice, showing similar results.  
Previous studies in other microbes have implicate the importance of O-antigen for resistance 
to phagocytosis, including Vibrio anguillarum, Burkholderia cenocepacia Salmonella enterica, 
Escherichia coli, Haemophilus ducreyi, and Neisseria gonorrhoeae  [166-171]. In E. coli, S. 
enterica, H. ducreyi and N. gonorrhoeae, it was noted that O-antigen allows for resistance to 
phagocytosis by masking the N-acetylglucosamine residues of LPS core polysaccharide, which is 
the ligand for the dendritic cell-specific intercellular adhesion molecule nonintegrin (DC-
SIGN)/CD209 [169, 171]. In V. anguillarum, it is speculated that O-antigen mask putative 
mannose residues that interact with the mannose receptors of skin epithelial cells [166]. We 
show that provision of mannose as a competitive inhibitor for mannose receptor, abrogated the 
increase susceptibility of 1244G7 to SP-A. These results suggest that the additional O-antigen 
mask putative mannose residues, preventing its interaction with mannose receptors that have 
been upregulated in the presence of SP-A.  
66 
 
In conclusion, we have shown that the addition of O-antigen subunit to Tfp confers increased 
virulence; and resistance to this virulence is associated with the presence of SP-A. We have also 
shown the O-antigen subunit in Tfp allows for resistance to SP-A-mediated lung clearance and 
phagocytosis, but not membrane permeability. Finally, we have shown that the increased 
susceptibility of the non-glycosylated mutant to SP-A-mediated phagocytosis is associated with 
the exposure of mannose residues.  
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FIGURES AND TABLES 
TABLE 2. Bacterial strains and plasmids used in this study 
Strain or plasmid Description Reference 
P. aeruginosa strains 
     1244 Wild-type [162] 
     1244G7 In frame deletion of the tfpO gene [162] 
     1244G7 (comp)  ΔtfpO mutant complemented with 
a copy of wild-type gene in trans
  
[162] 
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Fig. 16. The addition of O-antigen subunit to Tfp allows for increased virulence and resistance to 
SP-A-mediated phagocytosis. (a) Respiratory tract infections with wild-type 1244 versus 
1244G7 were performed by intranasal inoculation of anesthetized SP-A
+/+
 or SP-A
-/-
 mice. 
Mouse lungs were harvested 18 hours post infection for bacterial enumeration. Data are the mean 
CFU ± SE (n = 5-6 per group). 
*
p < 0.05 when comparing the bacterial loads between SP-A
+/+
 
versus SP-A
-/-
 infected by 1244 or 1244G7. 
#
p < 0.05 when comparing the bacterial loads 
between 1244 versus 1244G7 infecting the SP-A
+/+
 or SP-A
-/-
 mice. (b) The growth kinetics of 
1244 and 1244G7 bacteria were determined by measuring OD 600nm. The experiments were 
performed three times independently in triplicates. The representative growth curve from one out 
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of three independent experiments is shown. (c) The mortality rate of SP-A
+/+
 and SP-A
-/-
 mice 
infected with either 1244 or 1244G7.  
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Fig. 17. Histopathology of PA-infected lungs. SP-A
+/+
 and SP-A
-/-
 mice were infected with 1244 
or 1244G7 as described in Fig. 10. Representative H&E-stained lung sections from SP-A
+/+
 and 
SP-A
-/-
 mice (n = 5) 18-hour post intranasal instillation of 1244 (a, c) and 1244G7 (b, d) 
bacteria. 
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Fig. 18. The 1244G7 mutant is more susceptible to SP-A-mediated opsonization. (a-c) RAW 
264.7 macrophages were infected with either 1244 or 1244G7 in the presence or absence of hSP-
A. The ratio of ingested bacteria was expressed as fold increase in phagocytosed bacteria due to 
the effect of hSP-A. (a) Phagocytosis of 1244 and 1244G7 in the presence of different 
concentrations of hSP-A. (b) Time dependent phagocytosis of 1244 versus 1244G7 in the 
presence of 25 µg/ml hSP-A. (c) In vivo phagocytosis of 1244 versus 1244G7 in SP-A
+/+
 and SP-
A
-/-
 mice (n = 3). All phagocytosis experiments were independently performed three times in 
triplicates. The mean ± standard deviation from one representative experiment is shown. *p < 
0.05 when comparing the number of phagocytosed 1244G7 against 1244.  
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Fig 19. The increase susceptibility of 1244G7 mutant is associated with increase susceptibility to 
mannose receptor uptake. RAW 264.7 macrophages were pre-incubated with or without 1 mM 
D-mannose. It was then infected with either 1244 or 1244G7 in the presence or absence of hSP-
A. The ratio of ingested bacteria was expressed as fold increase in phagocytosed bacteria due to 
the effect of hSP-A. *p < 0.05 when comparing the number of phagocytosed 1244G7 with the 
presence of 1 mM mannose against untreated 1244G7. 
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Fig. 20. The addition of O-antigen subunit does not allow for increased resistance to SP-A-
mediated membrane permeabilization. In vitro ThioGlo
®
 assay. 1244, 1244G7 and 1244G7 comp 
were preincubated with 50 µg/ml hSP-A for 15 minutes. The bacterial-free supernatants were 
then mixed with ThioGlo
®
. Absorbance was measured at excitation wavelength 405 nm and 
emission wavelength 535 nm. w=with; w/o=without. *p < 0.05 when comparing the relative 
fluorescence unit (RFU) of SP-A treated versus non-treated bacteria.  
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CHAPTER 4: SUMMARY 
 
 During my preliminary examination, I proposed two hypotheses: 1. Tfp is important for 
PA resistance to SP-A-mediated antibacterial effects; 2. The addition of O-antigen moiety to Tfp 
allows for increase resistance to SP-A-mediated effects. Both of these hypotheses have been 
verified (see Chapter 2 and 3).  
 For my first aim, I first attempted to show the importance of Tfp to SP-A-mediated lung 
clearance. Because the relative decrease of bacterial load between from SP-A
-/-
 mice and SP-A
+/+ 
mice for both PAO1 and ∆pilA is similar, a straightforward link between Tfp and SP-A cannot be 
easily established. What is clear is that Tfp is important for resistance against lung clearance, 
both in the presence and absence of SP-A. One possible explanation to this is that other lung 
innate immune factors (i.e. phagocytic cells, cytokines, chemokines) within the airway spaces 
may compensate for the absence of SP-A. Next, I explored which specific aspect of SP-A-
mediated antibacterial effects to which Tfp affords resistance to. Using the gentamicin exclusion 
assay, I have shown that ∆pilA is consistently more susceptible to SP-A-mediated phagocytosis. 
To further show that this is consistent in vivo, I used C3H mice and their SP-A KO counterparts 
to evaluate in vivo phagocytosis. Again, I have shown that ∆pilA is more susceptible than wild-
type to SP-A.  More importantly, I have shown that ∆pilA complemented with a copy of wild-
type pilA gene regains its resistance to SP-A. SP-A mediated-phagocytosis is facilitated by 
enhanced aggregation of bacteria. By using GFP expressing PA strains, I have shown that ∆pilA-
GFP is susceptible to SP-A-mediated aggregation; while wild-type PAO1-GFP strain is not. 
Another antibacterial mechanism of SP-A is by directly killing cells via membrane 
permeabilization. Using two commercially available membrane permeability assay kits, ELF-97 
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(which measures a fluorophore-linked phosphatase substrate that enters leaky bacteria) and 
ThioGlo (which measures thiol containing proteins that leak out of the bacteria), I have shown 
consistently that ∆pilA is more susceptible than wild-type PAO1 to SP-A-mediated membrane 
permeabilization. This was further confirmed using bronchoalveolar lavage (BAL) from C3H 
wild-type and SP-A KO mice, where BAL the SP-A-containing wild-type mice permeabilized 
the ∆pilA mutant more readily than the BAL from the SP-A-/- mice. Finally, purified hSP-A or 
BAL from mice consistently kills more ∆pilA bacteria than its isogenic wild-type PAO1. 
 Further exploring the underlying mechanisms by which Tfp resist SP-A-mediated 
phagocytosis, I used both the extension and retraction gene mutants of Tfp to determine whether 
this increase susceptibility by ∆pilA is associated with the mere absence of surface Tfp or the 
total absence of Tfp both on the bacterial surface and intracellularly. Extension mutants, which 
don’t expresses surface Tfp but have Tfp protein intracellularly, did not show increased 
susceptibility to SP-A-mediated phagocytosis. This suggests that it is the total absence of Tfp 
(both intracellular and in the surface) allows for increased susceptibility to SP-A-mediated 
phagocytosis. Interestingly, retraction mutants, ∆pilT and ∆pilU, showed even higher levels of 
resistance to SP-A-mediated phagocytosis than the wild-type PAO1. These results suggest that 
hyperpilation (the phenotype of ∆pilT and ∆pilU) is covering/masking an unknown ligand for 
SP-A, allowing increased resistance to SP-A-mediated phagocytosis. I hypothesized that the 
ligands was one of the myriad nonpilus adhesins whose expression were compensatorily 
increased in the absence of PilA, causing an increase susceptibility to SP-A-mediated 
phagocytosis. To test this, I compared the SP-A-mediated phagocytosis on PA strains PAO1, 
∆pilA and ∆rpoN. RpoN has been shown to positively regulate the expression of Tfp and non-
Tfp adhesins. My results show that ∆rpoN bacteria are more resistance to SP-A-mediated 
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phagocytosis than both ∆pilA and wild-type, supporting my hypothesis. To further explore this 
hypothesis, I use ligand blot to determine whether there is an SP-A binding ligand (nonpilus 
adhesin) that is more expressed in ∆pilA but not wild-type and ∆rpoN. I have shown that an 18 
kDa membrane protein is more strongly expressed in ∆pilA than both wild-type and ∆rpoN. By 
mass spectrophotometry, I have determined that this ligand is OprH.    
 For my second aim, I proposed that the presence of sugar moiety, specifically O-antigen 
subunits, on pilin monomers allows the clinical strain 1244 to have increased resistance to SP-A-
mediated antibacterial effects. Using the mouse clearance assay, I was able to show that the 
∆tfpO glycosyltransferase mutant strain 1244G7 has a significantly increased clearance in wild-
type C3H compare SP-A KO mice, while 1244 did not. This shows that the absence of O-antigen 
decorating the pilin subunits on Tfp increases 1244G7 susceptibility to SP-A-mediated lung 
clearance. More importantly, I was able to show that while 1244G7 did not produce mortality in 
SP-A KO mice, 1244 did, showing that the additional O-antigen allows for increased virulence. 
Using piperacillin exclusion assay, I was able to show that 1244G7 is more susceptible than 1244 
to SP-A-mediated phagocytosis, but not SP-A-mediated membrane permeability. Finally, using 
mannose as a competitive inhibitor, I was able to show that the increased susceptibility of 
1244G7 to SP-A-mediated phagocytosis is abrogated, suggesting that 1244’s increased resistance 
is due to masking of putative mannose moiety by the O-antigen subunits.   
Future direction for our project would include confirming the importance of OprH as an SP-
A ligand. To undertake this, a nonpolar deletion mutant (ΔoprH) and as well as a ΔoprH strain 
genetically-complemented by a copy of the wild-type gene in trans would need to be 
constructed. These would then be tested against the existing SP-A functional assay in our 
laboratory, including gentamicin exclusion assay and membrane permeability kits. We also plan 
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to study the complex interaction of OprH with RpoN. Using real time-reverse transcriptase-
polymerase chain reaction (RT-PCR), we plan to quantify whether oprH mRNA is decreased in 
the absence of rpoN. Furthermore, we plan to examine the sequence and functional homology 
between OprH with other existing protein SP-A ligand such as Haemophilus influenzae P2 and 
Staphylococcus aureus EAP [89, 157]. Interestingly both OprH and P2 are outer membrane porin 
proteins, possessing β-barrel structures [155-157, 172]. Further examination of porins of other 
Gram-negative bacteria such as LKT of Mannheimia hemolytica, Apx of Actinobacillus 
pleuropneumonia and their possible function as SP-A receptors is warranted. Adhesins of Gram-
positive bacteria such as EAP of Staphylococcus aureus could also be explored as receptors of 
SP-A.   
 Also, further investigations describing the mechanism for the increased resistance allowed 
by the addition of O-antigen to Tfp against SP-A-mediated antibacterial effects are needed. 
Currently, we have two working hypotheses. Firstly, it has been shown that bacterial 
hydrophobicity is associated with increased phagocytosis [173]. Also, it has been shown that the 
glycosyltransferase mutant, 1244G7, is more hydrophobic than the WT, 1244 [162]. They 
speculate that this hydrophobicity is due to the loss of negatively charged trisaccharides (O-
antigen repeating subunits) [162]. Hence, we speculate that 1244G7 is more susceptible than SP-
A-mediated phagocytosis due to increased hydrophobicity. This is very plausible as SP-A have 
been shown to bind to hydrophobic ligand, namely lipid A [135]. To test this, first, we plan to 
purify the Tfp of both 1244 and 1244G7. Then, we would like to test whether the addition of Tfp 
of glycosylated 1244 would abrogate the increased susceptibility of 1244G7 to SP-A-mediated 
phagocytosis. The theory is that the purified charged Tfp of 1244 would repel or hinder the 
interaction of SP-A with the hydrophobic Tfp of 1244G7. An alternative experiment would be by 
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adding either the purified trisaccharide O-antigen subunit or the terminal sugar, pseudaminic 
acid. We would also use SP-A ligand blot to determine whether SP-A binds to these Tfps. Also, 
we would test whether it binds preferentially to 1244 or 1244G7 Tfp. Alternatively, a co-
immunoprecipitation of Tfp and SP-A could be performed. We predict that 1244 Tfp would bind 
more avidly to SP-A than 1244G7 Tfp.  
Secondly, it has been shown that SP-A binds to and enhance phagocytosis only in rough, but 
not smooth strains of E. coli [118]. This is explained by the fact that SP-A binds to lipid A [135]. 
It is hypothesized that the steric constraint of the bulky O-antigen and core polysaccharide 
prevents binding of SP-A to lipid A [118]. LPS O-antigen has also been shown to be important to 
resistance of non-SP-A-mediated phagocytosis by many authors [166-171]. Again, this is 
explained due to the steric block caused by the O-antigen to the the N-acetylglucosamine residue 
in the core polysaccharides, which is the ligand for DC-SIGN, the phagocytic receptors in 
dendritic cells [171]. In one paper, it has been shown that the resistance caused by O-antigen is 
associated with putative mannose receptors [166]. Currently, we have shown evidence that a 
similar mechanism exists with the 1244 PA strain. We plan to further refine our experiments 
with mannose inhibition by using lower concentration of mannose. Alternatively, we want to test 
other known sugars that are known to bind to SP-A, such as fucose and N-acetylglucosamine or 
combinations there of.  
 Taken together, I have shown that Tfp and its accessory sugar structures are important for 
resistance to SP-A-mediated antibacterial effects. Hence, a novel approach to CF treatment using 
exogenous SP-A administration, may be useful, as Tfp is missing in CF isolates.   
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